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 I 
Abstract 
Tissue engineering has shown a need for three-dimensional (3D) tissue scaffolds for 
cell growth as an improvement over slab scaffolds. We present a novel scaffold design and 
manufacturing process, utilizing biomorphic scaffold shapes based on computational 
models and defined by optimal surface area to volume ratios. Using these models and a 
low-cost 3D printer, we developed fractal-based biocompatible 3D tissue scaffolds that 
supported cell proliferation.  
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Chapter 1. Introduction 
Three-dimensional (3D) biodegradable scaffolds can support effective tissue 
regeneration and delivery of therapeutic molecules. One of the challenges in 3D tissue 
culture is the inability of nutrients to diffuse deep into a scaffold, resulting in cell death at 
the inner core (Rajagopalan & Robb, 2006).  Nutrient availability can be optimized by 
incorporating biologically inspired geometries into tissue scaffold design, improving 
scaffold function and cell growth. To achieve this goal, we improved scaffold material and 
geometries using a commercially available, affordable 3D printer, the MakerBot Thing-O-
Matic. We created fractal shaped 3D tissue scaffolds with greater surface area to volume 
ratios than current slab structures, to achieve optimal geometry and ensure the greatest 
availability of growth media to the cells in each tissue scaffold (Rajagopalan & Robb, 2006).  
We also developed a novel technique to fabricate 3D fractal tissue scaffolds and grow cells 
in vitro. 
There are many technologies in the current market place that aim to reduce the 
presence of a necrotic core in 3D cultures. One such method is the rapid casting of scaffolds 
using carbohydrate glass encapsulated in an ECM-cell mixture (Miller et al., 2012). The 
lattice dissolves in media, leaving behind the patterned vasculature within. Using this 
method, cells that are exposed to media within and around the scaffold remain viable with 
minimal necrosis within these 3D scaffolds (Miller et al., 2012).  This is an important proof-
of-concept that combines complex geometric patterns with vasculature by utilizing rapid 
3D printing. A second approach is the creation of a sacrificial lattice to allow for efficient 
media perfusion within the 3D tissue scaffold (Lee et al., 2010).   However, this approach 
limits perfusion to the X and Y directions, making it less than ideal for true 3D cell culture. 
Both of these existing approaches limit the types of complex 3D geometries that can be 
used. We propose that the use of biomorphic geometries can improve the efficiency of 
nutrient supply within 3D scaffolds as they already do in nature. Our design approach aims 
to develop 3D biocompatible tissue scaffolds using a commercially available and 
inexpensive desktop 3D printer. 
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Chapter 2. Literature Review 
This project explores strategies and fabrication methods for designing an optimal 3D 
tissue scaffold based on biomorphic fractal patterns using a 3D printer with a 
thermoplastic extrusion tip. In this chapter, we review, evaluate, and summarize 
background literature relevant to biomorphic fractal design, mathematical modeling of 
fractal systems, 3D printer specifications, biomaterial properties, biocompatible 
sterilization techniques, cell culture, current bioscaffold fabrication research, and pertinent 
current and past research in the field of Biomedical Engineering. 
2.1 Biomorphic Fractal Geometry 
A frontier in modern tissue engineering research is to utilize design cues from nature 
to optimize cell growth in tissue scaffolds by maximizing nutrient availability. In nature, 
many organisms increase their survivability by optimizing their surface area to volume 
ratios such that maximum nutrient transfer is achieved with the environment. This enables 
survival in suboptimal conditions; thus, over millions of years, many such organisms have 
evolved highly optimized shapes and structures to achieve this goal. Engineering using 
biomorphic design cues from such organisms provides a research shortcut to achieving 
better, more efficient nutrient delivery to cells cultured on manufactured tissue scaffolds. 
A number of universal design concepts must be considered when designing the 
optimal biomorphic tissue scaffold. Within practical limitations, the largest surface area 
possible per unit volume must be achieved, so the largest number of cells can adhere to the 
scaffold and receive adequate nutrition (Rajagopalan & Robb, 2006). Most importantly, 
pore size in the bioscaffold must be optimized for the cell type being cultured. According to 
Rajagopalan and Robb (2006), the best experimentally determined pore sizes are 5  m for 
vascularization, 5-15    for fibroblasts, 20    for hepatocytes, 100-350    for bone, and 
500    for fibrovascularization These pores must be interconnected with curved cross 
sections, while maintaining the rigidity required to grow the target cell type and the 
flexibility required for cell proliferation and locomotion (Rajagopalan & Robb, 2006). 
Achieving the optimal combination of these parameters for the target cell type is essential 
to producing a successful tissue scaffold, regardless of the geometry being utilized. 
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Two major pathways exist for the biomorphic design of tissue scaffolds – mosaic and 
fractal. Mosaic structures utilize pores with curved cross-sections, tessellated to create a 
3D repeating structure with sufficient structural integrity (Rajagopalan & Robb, 2006). In 
prior research, such structures have shown promise in providing cultured cells with 
sufficient nutrients; however, the required micro-geometry requires submicron printing 
accuracy and reproducibility that 3D printers within our price range cannot currently 
achieve. Fractal structures utilize geometry that is common in nature, from tree roots and 
branches to DNA. The use of fractal geometry enables tissue scaffolds to utilize the natural 
self-organization of cells and the optimal shape on which cells may grow. Additionally, such 
geometry is feasible from printers within our desired price range (<$2,500) because even 
inaccuracies and imperfections in the reproduction of each fractal can be considered fractal 
in nature. Thus, even these imperfections can potentially contribute to optimal nutrient 
delivery and cell growth. 
The fractal nature of a biological structure can be quantified through fractal 
dimension (D) and lacunarity (L). Fractal dimension is computed by counting border pixels 
as a function of sampling region (Smith et al., 1996). Lacunarity is computed by measuring 
the variation inside a fractal structure (Smith et al., 1996). Together, these metrics can be 
used to quantify the relative fractal nature of a system. Furthermore, they can be used to 
compare natural fractals to computer generated ones, making it easier to select the shapes 
that best replicate natural fractals. These two metrics allow for accurate determination and 
classification of fractal structure in biological systems, and may be used to develop 
mathematical analogs that can be digitized and used to create new tissue scaffolds. 
Fractal structures appear throughout nature, in clouds, rivers, blood vessel structure, 
lightning, DNA, trees, and more – that’s just a small sample. Fractal geometry, when found 
in nature, generally represents one of the most optimal shapes for the task for which it is 
being utilized by an organism (Smith et al., 1996). Some of the natural fractals that will be 
explored for the design and modeling of tissue bioscaffolds are: trees, coral, axons, blood 
vessels, and a class of organisms known as Xenophyophores.  
Blood vessels and neural axons are among the most studied natural fractal 
geometries. Tissues are innervated and vascularized in a fractal pattern – that is, the macro 
arrangement and branching structures of these vessels resemble each other at different 
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levels of zoom. This phenomenon is known as self-similarity. For example, a Purkinje 
neuron has a fractal dimension D = 1.89, while a mathematically generated Koch Snowflake 
fractal has a fractal dimension D = 1.26 (Smith et al., 1996). This indicates that some 
natural structures, such as neurons, exhibit greater fractal character than some artificially 
generated fractals. Many natural fractal structures contain two or more fractals integrated 
into one. In these cases, a simple calculation of fractal dimension will not accurately 
represent the fractal character of the system. However, if both fractal dimension and 
lacunarity are calculated, they can be used together to uniquely classify any natural fractal 
(Smith et al., 1996). However, such classification is beyond the scope of this project and will 
not be pursued further. 
Most parts of a tree – roots, branches, and leaves – utilize self-similar fractal 
structures to optimize nutrient transfer. Chandra and Rani (2006) demonstrated that the 
self-similar portions of plants, such as the branches or roots, could be modeled using the 
set of Noble numbers as a function of the golden mean. Using this method, they developed 
the following mathematical model for the generation of 3D trees, with a variety of 
customizable factors: 
     (    )  (   )             
Using this equation with different scaling factors, images such as the one in Figure 1 
were generated. 
 
Figure 1: Computer-Generated 3D Fractal Tree (Chandra & Rani, 2009). 
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Xenophyophores are interesting and almost entirely unique organisms which have 
evolved for millions of years, optimizing their surface area to volume ratios to survive in 
harsh environments at the bottom of the ocean. Their uniqueness is attributable to the fact 
that they are single celled organisms, yet they grow to relatively large sizes – up to 25 cm 
across. Figure 2 illustrates some of the different Xenophyophore morphologies that have 
been discovered living on the ocean floor in some of the deepest parts of the world’s 
oceans. In general, these organisms utilize complex systems of folds, sometimes in fractal 
patterns, to maximize their surface area to volume ratios. However, some Xenophyophores, 
such as items b and g in Figure 2, use complex networks of tubes and craters that can be 
utilized to optimize nutrient transfer when designing tissue scaffolds (Levin, 1994). 
Xenophyophore morphology may be replicated or adapted in tissue bioscaffolds to 
optimize the surface area to volume ratio enough for cells to adhere, differentiate, and 
proliferate as desired.  
 
Figure 2: Variation in Xenophyophore Morphologies (Levin, 1994)  
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2.2 MakerBot Thing-O-Matic 
We will be using a MakerBot Thing-O-Matic 3D Printer (TOM) for production of our 
tissue scaffold molds. The TOM was one of the first open-source personal 3D printers and 
has a large support community as well as significant continuing manufacturer support. It 
achieves 3D thermoplastic extrusion through a technique called fuse deposition modeling, 
which will be explained further below. Though it is now several generations behind in 
technology, it was originally available for purchase for $1,275.00; it accurately represents 
an affordable 3D printer as it is significantly less expensive than the professional 3D 
printing options. 
The TOM that we will be using for this project has a single StepStruder Mk6+ 
extruder, though dual extrusion is available as an optional, experimental modification. The 
materials that are officially supported and available for purchase are acrylonitrile 
butadiene styrene (ABS), polylactic acid (PLA), and water-soluble polyvinyl alcohol (PVA). 
The StepStruder Mk6+ is a thermal extrusion tip that operates at a maximum temperature 
of 230°C and uses a five-axis stepper motor to extrude plastic filament. Filament sizes 
between 1.75 mm and 3.00 mm may be used with this upgraded Mk6+ extruder, though 
non-standard sizes require calibration to achieve acceptable print quality. The motors in 
the TOM enable 2 μm positioning resolution in the lateral (X/Y) direction at a filament feed 
rate of at least 500 cm/min, and 5 μm positioning resolution in the vertical (Z) direction at 
a filament feed rate of at least 100 cm/min.  
The chosen thermoplastic can be extruded onto the heated build platform (HBP) 
included with this TOM, covered in aluminum, glass, Kapton (polyimide) tape, or blue 
painter’s tape. The maximum safe operating temperature of the HBP is 130°C. Using the 
default build platform and stepper motors, the maximum print size is 100 mm x 100 mm x 
100 mm. The TOM can print files using the ReplicatorG software in conjunction with 
Skeinforge. ReplicatorG accepts the .STL file format and, using Skeinforge and the 
calibrated printer settings, generates a .GCODE file that contains the full set of commands 
used to produce each print. .STL files can be created using a number of computer-aided 
design (CAD) programs, including Dassault Systèmes SolidWorks (MakerBot Industries, 
2012).  
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2.3 Material Properties and Selection 
Material selection is an important part of tissue scaffold design. While there are many 
factors in selecting the appropriate material, it is necessary for the material to meet certain 
criteria. Biomaterials can promote or hinder cell attachment, proliferation, organization, 
and differentiation. The optimal biomaterial for this project will have controlled 
degradation in a biological environment without releasing toxic substances. It should also 
provide for nutrient and waste transport, have cell-recognizable surface chemistries, and 
promote signal transduction pathways (Naderi et al., 2011). Porosity and connectivity 
determine which cell line is best suited for each application based on pore size and cell 
migration rates. It must also be possible to sterilize the chosen material in a manner that 
will not damage it or change its degradation rate.  
Primarily, the chosen material for the designed bioscaffold is compatibility with the 
MakerBot Thing-O-Matic 3D Printer. According to the MakerBot support website, the 
printer can extrude three different types of material: ABS, PLA, and PVA (MakerBot 
Industries, 2012). These materials may be used to create the tissue scaffold directly, or to 
create a mold which can be used in conjunction with a hydrogel to produce a fractal tissue 
scaffold. 
ABS is a thermoplastic that has excellent impact resistance, machinability, and 
thermoforming characteristics (Curbell Inc., 2008). Other key characteristics include high 
strength, high stiffness, and low cost. ABS is mainly used for rapid prototyping, machine 
panels, tote bins, and common consumer plastic materials. It is neither biodegradable nor 
biocompatible. While it is a good material for prototyping, it does not meet some of our 
final proposed design constraints outlined in Chapter 3.  
PolyLactic acid (PLA) is a biocompatible and biodegradable plastic that is also usable 
with the MakerBot Thing-O-Matic printer. This makes it a viable option for a scaffold 
construction material. Important properties of PLA are listed below in Table 1. It is 
assumed that the PLA sold by MakerBot in filament form will retain these properties. 
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Table 1: Properties of PolyLactic Acid (MatBase, 2009) 
Material Properties 
Quantity Value Unit 
Young's modulus 350 - 2800 MPa 
Tensile strength 10-60 MPa 
Elongation 1.5 - 380 % 
Bending strength 0.89 - 1.03 MPa 
Impact strength 0.16 - 1.35 J/cm 
Physical Properties 
Quantity Value Unit 
Melting temperature 150 - 160 °C 
Glass temperature 45 - 65 °C 
Density 1210 - 1430 kg/m3 
Water absorption 0.5 - 50 % 
 
Polyvinyl alcohol (PVA) is another option for the printing of 3D tissue scaffolds. 
MakerBot supplies it in a form that is biocompatible and water-soluble, fully degrading 
within 24 hours in an aqueous environment. These properties make it resorbable in 
biological conditions. Table 2 outlines some of the properties of the water-soluble PVA 
supplied by MakerBot.  
Table 2: Properties of Water Soluble Polyvinyl Alcohol  
(MakerBot Industries, PVA, 2012) 
Product Characteristics Value 
Melt flow index (190°C, 2.16 kg) 1.5- 3.5g/10min 
Melting point 160- 170°C 
Glass Transition Temperature 45 - 55°C 
Specific Heat 0.4 cal /g °C 
Density 1.25 – 1.35 g/cm3 
 
Generally, many different classes of materials are used in the development and 
production of tissue engineering scaffolds. Natural and synthetic biomaterials each have 
their own advantages and disadvantages for a wide variety of applications. Table 3 outlines 
some of the major differences between the two types of biomaterials. Due to the 
requirement of using plastic filaments in the Thing-O-Matic printer, we are limited to 
printing only synthetic materials for which we can find a supplier. 
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Table 3: Natural and Synthetic Polymeric Materials (Ng et al., 2012)  
 
 
The main advantages of natural biomaterials are low probability of rejection and low 
toxicity. However, natural materials are hard to produce in large quantities and have poor 
mechanical strength. On the other hand, synthetic materials have controllable properties 
and geometries, as well as good reproducibility potential. The disadvantage of using 
synthetic materials is that they carry a higher chance of rejection by the body, causing 
problems with in vivo implantation. 
For the purpose of this project, synthetic biomaterials are optimal because the 
degradation rates and mechanical properties of the polymers can be controlled. The only 
constraint for material selection is that the MakerBot Thing-O-Matic uses a thermal 
extrusion tip that works with thermoplastics in filament form (diameter < 3 mm). PLA and 
PVA are both delivered in this form, and any other thermoplastic that can be found in this 
form would also be a possibility. Any materials considered for use with the Thing-O-Matic, 
apart from the supported ABS, PLA, and PVA, would require further testing and method 
development before use. 
2.4 Sterilization Techniques 
When designing a device that will be used in cell culture and potentially implanted 
into a human body, sterilization is important to prevent contamination from foreign bodies, 
such as viruses, bacteria, fungi, and parasites. In our specific case, we will be using a variety 
of plastics – including ABS, PLA, and PVA – as well as hydrogels. To ensure that the 
hydrogels in which cells are cultured are sterile, the plastic used to create the mold must be 
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sterilized before cell seeding and dissolution of the mold material. Sterilization of the 
MakerBot Thing-O-Matic printer is not feasible, so the focus will be on directly sterilizing 
the mold immediately before use. A variety of sterilization techniques will be compared for 
utility, ease of use, and price to determine the optimal one.  
A key method of sterilization that eliminates microorganism contamination that can 
ruin a cell culture is by using heat. While we can use heat to sterilize any of the steel lab 
tools we will be using, we cannot use it for our plastic molds because they are 
thermoplastics, which will readily soften and change shape if heated. Additionally, even 
temperatures lower than the melting point of the plastic can cause warping in the shape of 
the structure due to resulting heat inconsistency between different parts of the mold. Thus, 
heat can be eliminated as an option for sterilization. 
A medical industry standard method of sterilization is by the use of ethylene oxide 
(EtO). This involves low-temperature addition of EtO gas to a chamber that contains the 
item to be sterilized. The low temperature is ideal for use with our thermoplastic molds, 
and the equipment required for EtO sterilization is already owned by WPI. A limitation of 
EtO sterilization is the amount of time it takes – approximately 15 hours for a full 
sterilization cycle. Our water-soluble PVA begins to degrade in as little as two hours, even 
at atmospheric humidity, so a 15-hour cycle is not feasible. While EtO is also harmful to life, 
there are no residual deposits found on sterilized items if a properly calibrated EtO 
sterilization chamber is used. Overall, EtO is a good option for the sterilization of 
thermoplastic tissue engineering molds, but the long timeframe is incompatible with our 
material choices (Conviser, 2000). 
Another sterilization method is by the use of ortho-phthalaldehyde (OPA). OPA has a 
number of advantages over other sterilization methods, including stability at standard pH, 
low toxicity to humans, sterilization times less than one hour, and effective sterilization at 
room temperature. For example, the FDA has cleared OPA sterilization as effective at 25°C 
with as little as 5 minutes of contact time. OPA must be cleaned thoroughly off the items on 
which it is used because it stains skin and tissues gray. Overall it represents a low cost, low 
toxicity, and quick sterilization method that should be tested for compatibility with our 
molds (Centers for Disease Control and Prevention, 2008).  
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A final sterilization method we will consider for sterilization of our tissue engineering 
molds is the dry sterilization process (DSP). This method is used primarily in the beverages 
industry for the sterilization of plastic containers, but has also found use in the medical 
field. It uses 30-35% hydrogen peroxide at temperatures 10-15°C above room temperature 
to sterilize samples over a very short timeframe – as short as six seconds. This is one of the 
best choices of sterilization procedure, but it seems to be a specialized, closed process on 
which little information is available. This suggests major costs may be associated with 
successful implementation, but suppliers will be contacted for potential discounts (Centers 
for Disease Control and Prevention, 2008).  
2.5 Fibroblast Physiology 
Fibroblast cells are the most abundant cell type in the body. They are primarily 
responsible for synthesizing extracellular matrix and connective tissue and play a major 
role in wound healing. These cells produce types I and III collagen, which form aggregates 
to create larger collagenous structures. Fibroblasts also secrete glycoproteins and 
polysaccharides to form extracellular matrix. These cells are essential in the body’s 
response to injury in the reparation of connective tissue. When injury occurs, the cells 
proliferate and fill the wounds to repair the body (Alberts et al., 2002). In 3D 
conformations, fibroblasts may exhibit extended or retracted conformations, while in 2D 
cultures, they appear flattened when they have attached to the culture surface. It is 
important to understand that they do not appear to have the same conformations between 
the different dimensional cultures (Grinnell, 2005).  
The NIH/3T3 fibroblast cell line was established in 1963 from Swiss mouse 
embryonic tissue by George Todaro and Howard Green at the New York University School 
of Medicine. The nomenclature, 3T3, refers to the protocol used to establish the line; 3-day 
transfer with inoculation of 3 x 105 cells. After about 20 generations, the cells became less 
contact inhibited, changed from diploid to tetraploid, and the growth rate of the cells 
increased. It took the scientists about three months culture time to establish this cell line 
with unlimited cell growth and new growth properties. The cells were cultured on tissue 
culture plates using Dulbecco’s Modification of Eagle’s Medium (DMEM) with 10% calf 
serum (Todaro & Greene, 1963).    
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2.6 Review of Three-Dimensional Tissue Engineering 
The goal of tissue engineering (TE) is to create a method of regenerating damaged 
tissues in vivo using allogeneic cells or a patient’s own cells. The current golden standard 
for treating tissue and organ disorders is organ transplantation. However, the needed 
amount of organs is much greater than the supply resulting in thousands of people going 
without treatment. TE combines the expertise and knowledge base of polymer chemistry, 
materials science, cell and molecular biology, and clinical medicine (Holzwarth & Ma, 2011) 
to satisfy the unmet needs for tissue engineered constructs in the clinics. The current 
research focus in tissue engineering is to develop a 3D scaffold that is reproducible, 
biomimetic of the extracellular matrix and mechanical surroundings of the tissue, support 
thick tissues without developing a necrotic core, has a controlled pore size, geometry, 
interconnectivity, spatial distribution, is biocompatible, resorbable, porous, and provides a 
structure that guides cells into differentiation, proliferation, and in vivo signaling (Miller et 
al., 2012).  The current state of literature suggests these qualifications can be better 
achieved by using a combination of microstructures and nanostructures (Ng et al., 2012). 
The combination of these two physical attributes holds the potential to more accurately 
mimic in vivo structures, and influence cell adhesion, proliferation, morphogenesis, and 
differentiation (Ng et al., 2012). The variation in mechanical, chemical and physical scaffold 
characteristics causes the cells to behave in different ways. Researchers aim to discover the 
ideal combinations of properties a scaffold requires to replicate in vivo structures. The 
properties that impact cells on 3D scaffolds are: chemistry, topography, geometry, 
functionalization with biological molecules, porosity, pore size, pore configuration, fiber 
diameter, scaffold dimension, scaffold configuration, degradability, mechanical strength, 
ionic charges, and electrical conductivity. The required properties for optimal cell viability 
depend on the cell type being cultured (Ng et al., 2012).  
3D tissue scaffolds have many advantages over 2D scaffolds, most notably the ability 
to mimic the dimensional structure of the human body. Growing cells on a 3D scaffold 
impacts numerous components of the culturing conditions. These components include; cell 
attachment to the scaffold and the formation of bridges between fibers, slower 
proliferation rate due to surface attachment, longer in vitro culturing periods due to the 
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high surface area, rapid function execution, amount of healthy non-apoptotic cells, smaller 
more spherical structures, increased production of ECM and adhesion proteins, in vivo ECM 
mimicry, and 3D cell morphology (Ng et al., 2012). The combination of the correct physical 
and chemical properties in a scaffold will allow for tissue and organ regeneration in vitro, 
posing a possible alternative to organ transplantation with a patient’s own cells.  
2.6.1. Tissue Engineering Approaches 
The broad base of ideal components in a TE scaffold resulted in numerous 
approaches to the solution. There are four categories of TE scaffolds; gel-like scaffolds, 
constant geometry and structure scaffolds, fibrous scaffolds, and amorphous foam 
scaffolds. Each scaffold offers its own advantages and disadvantages to mimicking the 
organization of native structures. To determine which scaffold is appropriate for a certain 
situation, the native shape, mechanical properties, ability to direct cell-cell and cell-matrix 
interactions, and the extent of porous structures for efficient mass transport should be 
evaluated and compared to the desired in vivo structure. Some of the fundamental 
components for scaffold success are porosity allowing cell penetration and nutrient/waste 
removal (approximately 5-10 times that of the cell diameter) (Peltola et al., 2008), 
mechanical properties matching application, biocompatible, biodegradable, and the 
scaffold contains nanofibrous features that attempts to mimic collagen, the largest 
component of the ECM (Holzwarth & Ma ., 2011).   
2.6.2. Hydrogels 
Hydrogels are water-swollen, cross-linked polymeric structures containing covalent 
bonds between monomers, physical cross-links from chain entanglements, and van der 
Waals interactions between chains.  Hydrogels are the TE scaffold of choice for soft tissue 
replacement due to their mechanical and chemical properties. Hydrogels are composed of 
mostly water, and have characteristics similar to that of ECM including flexibility, water 
retention capabilities, rubbery and soft consistency, and permeability of oxygen and 
metabolites. In addition, hydrogels have a minimal tendency to adsorb proteins, can be 
modified to create specific protein affinity, and self-assemble upon temperature 
modification. These characteristics allow hydrogels to be tailored to specific locations in 
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the body (based on protein surroundings), and form a gel upon injection into the body 
(Vlierberghe et al., 2011). 
Hydrogels are classified by characteristic variations of preparation methods, 
mechanical and structural characteristic, and overall charge. These broad categories result 
in hydrogels that are homopolymeric, copolymeric, neutral, anionic, cationic, amourphous, 
semicrystalline, hydrogen bonded, supramolecular and hydrocolloidal. These property 
variations provide options for selection based on body and cell characteristics.  
2.6.3. Fibrous Scaffolds 
Fibrous scaffolds are the conglomerations of individual fibers into 3D composites. 
Fibers can be combined to mimic the collagen components of the extracellular matrix. 
Synthetic and natural polymeric structures can be used to create fibrous scaffolds that 
mimic the in vivo cellular microenvironment, and have good structural penetration, 
porosity, chemical and thermal stability, mechanical strength, and physical properties. 
Fibrous scaffolds can be created using various methods. These methods are fiber bonding, 
needle punch, electrospinning, 3D printing, and micro embossing. All of these methods 
allow for the ability to control pore size; one of the main benefits of fibrous scaffolds is the 
ability to create pores with constant pore size (Ng et al., 2012). 
2.6.4. Amorphous Foam Scaffolds 
The final type of 3D tissue engineered scaffolds is an amorphous foam scaffold. 
Particulate leaching, phase separation, gas foaming, and solid freeform fabrication are all 
methods that can be used to create amorphous foam scaffolds. Amorphous foams offer the 
ability to create highly porous scaffolds; however, none of the methods used to create foam 
scaffolds can create constant pore diameters that would be desired for consistent tissue 
morphology.  
2.6.5. Three-Dimensional Tissue Engineering Scaffold Fabrication Methods 
The various fabrication methods for creating a 3D TE scaffold are grounded in the 
bottom-up approach. Nature, including the human body, is composed of small simplistic 
sub-units, that when combined in 3D conformations create complex structures. Some 
examples include: nephrons, muscle fibers, and the liver lobules (Suri et al., 2011). The 
fabrication methods that are used to create TE scaffolds are: solvent casting, particulate 
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leaching, gas foaming, fiber meshes, fiber bonding, phase separation, melt molding, 
emulsion freeze drying, freeze drying, solution casting, micro embossing, 3D printing, 
electrospinning, needle punch, and solid freeform fabrication (rapid prototyping) (Ng et al., 
2011; Peltola et al., 2008). 
2.6.6. Rapid Prototyping 
Rapid prototyping (RP) is one fabrication method for developing 3D TE scaffolds. It is 
based on an additive process in which complex structures are constructed layer by layer 
based on a CAD model. RP is one avenue of addressing the inability to control pore size, 
geometry, interconnectivity, and spatial distribution of 3D scaffolds. Stereolithography, 3D 
printing, selective laser sintering, and fused deposition modeling all fall under the RP 
umbrella.  These methods are employed to make scaffolds for hard tissue replacement. RP 
has several advantages that make it a good option for 3D scaffold fabrication; speed, 
customization, efficiency, patient specificity, economical, reduced constraints allowing the 
creation of complex geometries, composition variation, positional variation, controlled 
porosity, and does not require the use of organic solvents. Despite these advantages, there 
are some drawbacks to RP including the material fabrication compatibility, material 
entrapment within the scaffold during fabrication, high temperatures used during creation, 
and the unknown compatibility with sterilization techniques. While further investigation is 
needed for RP, the advantages outweigh the disadvantages, making RP a feasible option to 
pursue for TE scaffold fabrication (Peltola et al., 2008). 
2.7 Previous Publications and Approaches 
Tissue engineering has rapidly developed since its commencement and is ever-
changing. Researchers publish new work and discover novel methods for fabricating 3D 
scaffolds every year. Fortunately, a portion of this work has been accomplished through 3D 
printing.  This section outlines some of the work that has been generated and the different 
approaches each research team took in regards to building a 3D scaffold.  
While there are many ways to approach this issue, one method is using rapid casting 
of patterned networks. In this paper, the research team printed a rigid 3D construct using a 
3D printer and carbohydrate glass filaments (Miller et al., 2012). Once the lattice was 
printed, extracellular matrix (ECM) and cells were poured around the device encapsulating 
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the entire construct. Then media allowed for the dissolution of the lattice, leaving behind 
the patterned vasculature within. Once flow rate of media through the vasculature was 
established, cell viability tests were performed. Using this method, cells that were exposed 
to media within and around the scaffold were viable thus reducing the amount of necrotic 
core that can form within these scaffolds. This is an important proof-of-concept test that 
combines both geometric patterns and vasculature with rapid 3D printing.  
Additionally, instead of creating a sacrificial lattice, the fabrication of multilayered 
systems with channels is a possibility. In this review by Lee et al. (2010), a natural hydrogel 
was created from collagen and, using a 3D bioprinter, multiple collagen layers were 
printed. In between these layers, a sacrificial gelatin pattern was printed that would be 
liquefied after the layered construction was complete. This enabled the tissue scaffold to 
have media perfusion in the X, Y directions, but not in the Z direction. This is a clever 
approach because hydrogels more accurately mimic soft tissue and can be used to create a 
more realistic environment for cell culture.  
While Lee et al. (2010) did not culture cells on their hydrogel scaffold; Liu et al. 
(2008) cultured human mesenchymal stem cells (hMSC) on a collagen hydrogel. This team, 
instead of directly printing their scaffold, printed a mold to fill with collagen (Lee et al., 
2010). Once the mold was dissolved, only the desired collagen structure remained. 
Ultimately, this group found that, by crosslinking the hydrogel, they were able to create 
better cell adhesion and proliferation on the collagen scaffold.  
Although hydrogels are a useful tool for tissue engineering applications, they are very 
difficult to handle and manufacture. Their fragility and limited diffusion capabilities must 
be addressed. Huang et al. (2011) discussed recent advances in the fabrication and 
functionality of these scaffolds. The surface to volume ratio of cells to media flow has been 
a major issue in the tissue engineering field. However, by creating porous hydrogels, one 
allows for cell growth, tissue invasion, and nutrient transport. While the mechanical 
properties of hydrogels are driven by pore size and density, pores can be manufactured 
and controlled by methods such as particulate leaching, freeze drying, gas foaming, phase 
separation, and electrospinning. It is also important to consider pore distribution. Another 
method reviewed was embedding the hydrogels in microfluidic channels. These constructs 
can closely mimic natural tissues and recreate their spatial complexities while maximizing 
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perfusion capacity. Micro-needle templates, fiber templates, soft lithography, 
photopatterning, and bioprinting are all techniques used to create the microfluidic layered 
channels. The reviewed methods each have their advantages and disadvantages, such as 
changes in repeatability, accuracy, and ease of use, which must be considered when making 
a final selection. 
While hydrogels can be made from many different types of materials, usually they are 
either made from purely natural or synthetic materials. Shim et al. (2011) used a 
combination of these two types of materials to form a hybrid scaffold. In this novel 
approach, synthetic biomaterial slabs were printed and hydrogel was infused between 
every other slab to form an alternating pattern. Then, layer-by-layer, this processing was 
repeated, rotating each of the next layers 90° and stacking them to the desired height. By 
doing so, a natural hydrogel scaffold was created which was supported by a synthetic 
biomaterial frame that included pores for cell growth and proliferation (Shim et al., 2011). 
Another approach to creating a 3D tissue scaffold is by layering polydimethyl-
siloxane (PDMS) in a microfluidic device. By using PDMS, high gas permeability can be 
obtained, enabling cells to attach and proliferate (Leclerc et al., 2003). The main advantage 
of this technique is the ability to create the microfluidic device using molds, thus being able 
to culture cells directly onto this device. Leclerc et al. (2003) also created a protocol for cell 
culture in PDMS microfluidic devices, including sterilization procedures and surface 
treatments  
Many of the researchers listed in this section have taken different approaches to 
solving the same issue. They have each had some measure of success and their research is 
key in deciding which direction to pursue in the completion of this project.  
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Chapter 3. Project Strategy 
The goal of this project is to design and model a 3D tissue engineered scaffold using 
an inexpensive 3D printer in order to culture NIH/3T3 cells and eliminate necrotic cores 
within the scaffold.  This chapter outlines the steps and methods used to create and 
prioritize the objectives and constraints of this project in accordance with our client 
statement. Lastly, a project approach section outlines our goals for our project and a 
strategy for completing them.  
3.1 Initial Client Statement 
Our initial client statement as summarized by our advisor and client, Professor 
Domhnull Granquist-Fraser: 
“Cells developing in three-dimensional (3D) tissue scaffolds rapidly develop a 
necrotic core. To improve scaffold function, a vascularized network could be 
incorporated into the system. We aim to optimize the scaffold material and 
geometry by use of a MakerBot Thing-O-Matic 3D printer. In addition, the 
surface to volume ratio of media to cells throughout the scaffold will be 
maximized.”  
After creating this initial client statement from Professor Fraser’s summary of the 
project, the team developed a list of questions to ask at the next meeting with the team’s 
advisor. The questions asked helped to clarify the problem and what the client wanted so 
that the design process could progress.  
The next part of this was to decide who the stakeholders would be for the final design 
and product. By doing so, the scope of the project was revealed and certain objectives that 
were not otherwise clear were solidified. While Professor Domhnull Granquist-Fraser is the 
main advisor and client for this product, other clients could be other researchers and 
professors in the Biomedical Engineering department that would benefit from the creation 
of a 3D, rapidly produced scaffold. The ultimate users of this device are research teams and 
doctors working on tissue regeneration for large-scale wounds. The design team consists of 
Kellie Chadwick, Kali Manning, Johan Skende, and Sarah Walker. All members worked to 
clarify the problem in order to satisfy the needs and wants of the client and potential end 
users.  
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3.2 Objectives and Constraints 
After the team completely understood the initial client statement, objectives and 
constraints were created based on these needs. Objectives are tasks and goals for the 
project to ensure the creation of a quality product. They should be met by the final design. 
Constraints must be incorporated into the final design for the project to be deemed a 
success. Below are lists of the objectives and constraints for this project and descriptions 
for each: 
Objectives: 
 Optimal Geometry: The geometry of the scaffold must recreate a fractal pattern and 
evenly disperse media through the scaffold in order to reduce the necrotic core.  
 Optimal Material: The material used for the scaffold must be relatively inexpensive, 
be biocompatible, resorbable, be compatible with the MakerBot Thing-O-Matic, and 
be able to be sterilized.  
 Reproducibility: The scaffold design should be modeled in SolidWorks, be able to be 
mathematically modeled in MatLab, have a consistent surface area to volume ratio, 
and have a consistent precision rate.  
 Rapid Production: The scaffold must be made using the MakerBot Thing-O-Matic 
and be created within a designated time frame.  
Constraints: 
 Manufacturability 
 Biocompatible 
 Resorbable 
 Stay within budget ($500) 
 Scaffold must be printed on MakerBot Thing-O-Matic 
 Must be smaller than 100 mm x 100 mm x 100 mm (Build Platform size) 
 Stay within 28 week time limit 
 
3.2.1. Quantitative Analysis of Objectives 
After the team established all objectives for this project, visual models were made so 
the team could prioritize all of the wants and needs of the client. Pairwise Comparison 
Charts and objectives trees were consulted to determine the importance and hierarchy of 
the team’s design goals. Below are the models used in analyzing the objectives. 
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Figure 3: Objectives Tree 
 
The above objectives tree (Figure 3) breaks down all of our main objectives into sub-
objectives therefore more clearly defining what each objective encompasses.  
 
 
 
 
3D Printed Tissue 
Scaffolds  
Optimal Geometry 
Even media 
dispersion 
Achieve fractal 
pattern 
Optimal Material 
Cost 
Biocompatible 
Resorbable  
Printer 
compatibility 
Sterilizable 
Reproducability 
Can be made in 
SolidWorks 
Modeled in MatLab 
Within precision 
tolerance 
Consistent surface 
area to volume ratio 
Rapid Production 
Must use MakerBot 
Thing-O-Matic 
Consistently stay 
within designated 
time frame 
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Table 4: Pairwise Comparison Chart 
 Optimal 
Geometry 
Optimal 
Material 
Reproducibility Rapid 
Production 
Totals 
Optimal Geometry  
0.5 1 1 2.5 
Optimal Material 
0.5 
 
1 1 2.5 
Reproducibility 0 0  1 1 
Rapid Production 
0 0 0 
 
0 
 
The Pairwise Comparison Chart in Table 4 indicated that the most important 
objectives were creating the most optimal 3D tissue scaffold geometry while using the best 
material for the application. Reproducibility scored lower than these objectives because 
natural fractals incorporate a level of randomness, so even if they are not reproduced 
perfectly each time, they will still be fractal. Rapid production was a desire expressed by 
the client and the team will work to accomplish this as well if the other objectives are met 
first.  
3.3 Revised Client Statement 
After meeting with the client and reviewing the objectives and constraints, the team 
revised the initial client statement to read: 
“Cells developing in three-dimensional (3D) tissue scaffolds rapidly develop a 
necrotic core. To improve scaffold function, an optimal geometry can be 
incorporated into the system. We aim to optimize the scaffold material and 
geometry by use of an inexpensive 3D printer. To do this, the team will create a 
biologically inspired geometric 3D CAD model to design and mathematically 
optimize the surface to volume ratio of media to cells throughout the scaffold. 
The team will also develop a novel technique to fabricate the scaffold and grow 
cells in vitro.” 
This statement more accurately represents the ultimate goal of the project and 
describes what aspects the final design should have.  
3.4 Project Approach 
In order to complete this project and be successful, the project constraints must be 
met. The following describes the methods used to accomplish each of these goals. The main 
constraint of this project is printing the scaffold with the MakerBot Thing-O-Matic. This 
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constraint was set by the client; it is essential to the successful design of our tissue 
scaffolds. The scaffold printed on the MakerBot must be smaller than 100 mm x 100 mm x 
100 mm, as that is the size of the effective print area on the heated build platform of the 
Thing-O-Matic.  This can be accomplished by limiting the size of the design in CAD and 
ensuring a central location of the scaffold on the build platform. Additionally, any design 
that is created must be printable within the limited abilities of the MakerBot Thing-O-Matic.  
Another primary constraint of this project is scaffold material selection.  The material 
chosen must be compatible with the MakerBot Thing-O-Matic. The MakerBot Thing-O-
Matic only supports the use of ABS plastic, PLA, and PVA. Material selection is also reliant 
on the biocompatibility and non-toxic degradability of each plastic. While PLA and PVA are 
biocompatible, ABS plastic is not and therefore that material must not be used in the tissue 
scaffold. In addition, PLA and PVA are biodegradable, while ABS plastic is not. Thus, our 
material choices are limited to those that are compatible with the Thing-O-Matic and meet 
the other design constrains – PLA and PVA.  
In general, this project must stay within the 28-week time limit of the MQP as 
designated by the Worcester Polytechnic Institute (WPI) and indicated in our Gantt Chart 
(Appendix A). The budget for this project is $500, given to the team by the Biomedical 
Engineering Department at WPI. This means that the cost of all materials used for the 
scaffold must be less than $500 unless special permission or funding is obtained, or 
materials are donated. 
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Chapter 4. Alternative Designs 
Design alternatives in any engineering project are key to the design process and 
provide important information and considerations to all aspects of the project. In this 
section, design functions and variations of the design are outlined to determine the optimal 
final design. In this particular project, two rounds of design alternatives must be 
considered. Firstly, the manufacturing and fabrication methods of creating a 3D tissue 
scaffold are discussed. This is an important part of the process because while there are 
many methods used to manufacture these scaffolds so that they do not develop a necrotic 
core, there are only a few options when using an inexpensive 3D printer. Secondly, the 
actual biomorphic structure that will be used in the scaffold will be discussed and 
determined. Many fractal patterns are found in nature, and we must determine if there is a 
correlation between the surface area to volume ratios of each fractal and the resulting cell 
growth and proliferation data (Smith et al., 1996).  
4.1 Needs Analysis 
One of the most important requirements in a design project is determining what the 
client wants and needs from the design. Based on this consideration, functions were 
brainstormed from the final client statement as stated in Chapter 3. In particular, the 
driving force for this project is the need for a 3D tissue scaffold that does not develop a 
necrotic core due to insufficient nutrient delivery. To accomplish this, we will test 
biomorphic fractal geometries to determine if the surface area to volume ratios are linked 
to cell proliferation and growth. This biomorphic fractal geometry must be mathematically 
modeled, imported into a 3D CAD program, placed in an appropriate configuration for 3D 
printing, and exported for printing on the MakerBot Thing-O-Matic. 
Based on our project constraints, the final design should be biocompatible, 
resorbable, manufacturable with the MakerBot Thing-O-Matic, and smaller than the size of 
the printer’s build platform (100 x 100 x 100 mm). These constraints represent 
requirements of the project that must be fulfilled to have a successful outcome. 
The team created a design matrix to determine the relative importance of the needs 
and wants of the client, which can be seen in Table 5. The assigned weights are based on a 1 
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to 10 scale, 1 being the least important and 10 being the most important. This will aid in 
prioritizing the needs to produce a design in line with the clients’ needs. 
Table 5: Needs Analysis 
Need Priority Level  (1-10) 
Does not develop a necrotic core 10 
Biologically inspired geometry 5 
Optimal geometry 7 
Optimal material 9 
Biocompatibility 10 
Resorbable 7 
Build Size (100x100x100mm) 10 
Manufactured using the MakerBot Thing-O-Matic 10 
 
4.2 Functions and Specifications 
Determining functions and specifications is a necessary and important aspect of any 
engineering design project, to ascertain what the design must do and by what it is limited. 
We determined four main functions for our fractal 3D tissue scaffold: it must not develop a 
necrotic core, must maintain cell viability, have uniform media dispersion and nutrient 
flow, and mimic fractal geometries found in nature. 
Our first function specifies that our scaffold must not develop a necrotic core. The 
overall goal of this project is to develop a 3D tissue scaffold that does not develop a necrotic 
core, unlike some current industry applications. The scaffold must also maintain cell 
viability. If the majority of cells die, we must review and revise our cell culture protocol, 
such as our material and media selections. The nutrients in the cell culture media must be 
evenly dispersed for all of our cells to survive, proliferate, and differentiate. This can be 
achieved by our delivery system as well as our geometric structure. The shape of our 
scaffold must mimic a fractal biomorphic structure as directed by our client statement. 
Fractal patterns in nature have been shown to have the optimal surface area to volume 
ratio, which can be applied to media flow in channels (Smith et al., 1996). 
Specifications stemming from our functions are that the inner cell viability must be 
greater than 50%, the scaffold or material must be resorbable and biocompatible, the 
geometric structure should be able to be rapidly produced within an hour, and that the size 
of the structure should be less than 100 x 100 x 100 mm.  
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The cell viability, a measure of necrotic core formation and severity, must remain 
greater than 50% to be deemed acceptable. If more than half of the cells have died, the 
design and/or cell culture protocol must be reconsidered. The material used to create the 
scaffold must be biocompatible and resorbable in order to be implantable in vivo. If it is not 
compatible, there is a chance for rejection and cell death. If it is not resorbable, there could 
be complications from particles released in the body or mechanical disadvantages 
associated with the selected material. The scaffold should be printed, sterilized, and seeded 
within one hour to be considered rapid production. This rate has been determined by the 
team as a goal for the overall project. The size of the structure is limited by the Thing-O-
Matic’s build platform and cannot be any larger than 100 x 100 x 100 mm. The above 
functions and specifications are all critical to the successful completion of our design and 
the creation of alternative designs. 
4.3 Design Alternatives 
The nature of our project required two separate design iterations. The first round of 
design alternatives generation was performed to determine which method of fabrication 
best fits our objectives, goals, functions, constraints, and specifications. Our team came up 
with four design alternatives for this determination. Our second round of design 
alternatives generation focused on designing the geometry of our scaffold. We used MatLab 
to mathematically determine what design was most appropriate. The team designed a 
series of fractal models to find the most optimal design. We built the fractals and then 
simulated the surface area to volume ratio to find the model with the highest ratio. Based 
on these two iterations, the final design was chosen and pursued with further testing. The 
final design verification test will be a live dead assay of the cells to determine cell viability. 
All of the design methods explained are compatible with this final verification method.  
4.3.1. Fabrication Alternatives 
As previously stated, the team chose four fabrication methods based on the 3D 
printing constraints to create a scaffold. These four methods were printed biomaterial 
tissue scaffold, hydrogel mold, sacrificial lattice, and cells embedded in the material. 
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Printed Biomaterial Tissue Scaffold 
This design approach is the most classic of our alternatives, applying the approach of 
directly printing the tissue scaffold. The printed material would serve as a structural 
scaffold. The material used in this model is either PLA or water-soluble PVA.  However, 
since neither of these materials can culture cells directly on their surface, the scaffold 
would need to be coated in collagen. The cells could then be seeded on the collagen, and the 
scaffold submerged in media (DMEM with 10% FBS (fetal bovine serum)). Over time, the 
biomaterial scaffold will degrade, leaving the collagenous structure with cells remaining. 
The cells would be cultured between 10 and 14 days, culminating in a live dead assay. 
Figure 4, shown below, illustrates a simple schematic of this process.  
 
Figure 4: Schematic of Printed Biomaterial Tissue Scaffold 
 
Hydrogel Mold 
This design approach requires printing a mold for the scaffold. The inverse of the 
scaffold structure will be printed with a resorbable material (either PLA or water soluble 
PVA). The resulting void will be used as a mold for a hydrogel. This hydrogel will serve as 
the scaffold. Cells will be seeded onto the hydrogel, and then the hydrogel will be set. The 
setting procedure must be rapidly accomplished to assure the scaffold will not start 
degrading before setting can be achieved. The hydrogels therefore could be thermal set 
hydrogels, which swell at body temperature. Gradually, the mold will degrade leaving 
behind the hydrogel cell complex submerged in media. The hydrogel will not resorb, 
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serving as the structure of the tissue. Figure 5 below shows a step-by-step schematic of the 
fabrication process using a hydrogel mold. 
 
Figure 5: Schematic of Hydrogel Mold 
Sacrificial Lattice 
The third fabrication method is printing a sacrificial lattice. This would be used to 
create a network of interpenetrating channels within the scaffold. The desired network 
would be printed (with either PVA or water-soluble PLA), and then coated with ECM or 
collagen. The cells would then be seeded on the collagen, and the printed lattice degraded. 
After degradation, the scaffold would consist of a collagen base with interpenetrating 
channels for media dispersion. A brief schematic of this fabrication process is shown below 
in Figure 6.  
 
Figure 6: Sacrificial Lattice Schematic 
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Cells Embedded in Biomaterial 
The final fabrication method was inspired by the Bioplotter®, a 3D printer that prints 
cells and the scaffold material simultaneously. This would remove intermediate steps 
required in the three previous designs. Figure 7 displays a schematic of this design 
alternative.  
 
Figure 7: Embedded Cells Schematic 
 
4.3.2. Geometric Alternatives 
The development of these alternatives was based on nature inspired geometric 
fractals. Organisms that employ fractal geometries in nature maximize their ability to 
deliver nutrients. This is the motivation for basing our selections on nature inspired 
fractals. Some of the many natural fractal geometries we will be considering for inspiration 
are trees, coral, Xenophyophores, and nerves and blood vessels. These fractals are shown 
below in Figure 8 through Figure 11. 
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Figure 8: Tree Fractal (Chandra & Rani, 2009) 
 
 
Figure 9: Coral (Anonymous, 2012) 
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Figure 10: Variation in Xenophyophore Morphologies (Levin, 1994) 
 
 
 
Figure 11: Nerves (National Institute of Health) 
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4.4 Feasibility Study 
There are several aspects of this design project that must be evaluated for feasibility. 
The broad categories are material feasibility, fractal geometry feasibility, and printer 
capability. Verification of material feasibility will include classifying the degradation of ABS, 
PLA, and PVA in water. Printing process feasibility, reproducibility, and accuracy will be 
determined by printing in ABS, PLA, and PVA using the MakerBot Thing-O-Matic 3D printer. 
Test prints of both PLA and PVA – the materials that will be used for the prototype and final 
experiment respectively – will be used to determine the optimal extrusion rate, 
temperature, build platform material, infill %, number of shells, layer height, and raft. 
These numbers, once determined, will be kept constant for the remainder of the 
experimental validation. 
Our product design is based around printing a 3D fractal shape as a mold, then 
allowing that shape to dissolve in water after it has served as the template for a cell-laden 
hydrogel. Of all of the materials compatible with the MakerBot Thing-O-Matic, ABS shows 
no degradation in water, so it is not appropriate for the final design. PLA does degrade, but 
over a period of months, which is not compatible with our target timeframe. Therefore, 
PVA is the only material appropriate for our target design, and will be the only one 
considered. The degradation of the PVA filament will be tested in water to determine the 
feasibility of our final design. 
Next, we will evaluate whether our target fractal geometries can be printed using our 
MakerBot Thing-O-Matic 3D printer. We will accomplish this by attempting to print each 
design at different settings (Extrusion Speed, Filament Diameter, Shells, and Infill %) until 
the optimal settings are found that enable each design to be printed. Filament diameter is 
especially important because, although the filament we are using will remain at a constant 
diameter, changing the software value will cause the printer to extrude either more or less 
than what is programmed in the .GCODE file. This strategy can be used to clean up fractal 
molds that are messy and irreproducible because they are printed with more plastic than 
the shape requires. Surface area and volume for each fractal will be determined by using 
the Netfabb Cloud utility to process each .STL file. This utility returns surface area and 
volume ratios for each fractal. These values will be processed by an algorithm we create to 
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generate the surface area and volume for the fractal hydrogel scaffolds created from each 
PVA mold.  
4.5 Experimental Methods 
All of the following methods were conducted in accordance with standard guidelines 
and protocols provided by various sources. 
4.5.1. NIH/3T3 Cell Culture Protocol 
All cell culture work done throughout the entirety of this project followed the 
standard cell culture protocols. Cells were cultured in Dulbecco’s Modified Eagle Medium 
(DMEM) containing Fetal Bovine Serum, Glutamax, and Penn-Strep with concentrations 
according to Table 6. The primary experiments conducted were with regard to the selected 
hydrogel. These experiments included gelation time, thickness, cell density studies, and cell 
dispersion studies. The team worked with NIH/3T3 cells throughout the entirety of the 
project. The following sections will explain those studies and their purpose in more detail. 
 
Table 6: Complete Media Protocol  
Component Stock Solution Volume (mL) 
Final 
Concentration 
DMEM basal media  88.0  
Penn Strep 100X 1.0 1X 
L-Glutamine/Glutamax 200 mM 1.0 2 mM 
FBS  10.0 10% 
Total Volume  100.0  
 
Subculturing 
 NIH/3T3 cells were cultured on 100 mm tissue culture plates (CellTreat) at 37°C 
and 5% CO2 until achieving ~80% confluency. At this point the cells were passaged. The 
protocol followed for passaging the NIH/3T3 cells is as follows: 
1. Aspirate media 
2. Rinse cells with 5mL DPBS 
3. Aspirate DPBS 
4. Add 3mL of 0.05% trypsin 
5. Incubate for 5 minutes at 37°C 
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6. When cells are floating and circular in conformation neutralize the trypsin with 2mL of 
complete media (Table 6) 
7. Transfer the cell suspension into a 15mL conical tube  
8. Centrifuge the cells at 200g for 10 minutes to form a pellet 
9. Aspirate the media from the pellet and re-suspend in 5mL of complete media 
10. Add 1mL of the re-suspended cell suspension to a 100mm tissue culture plate  
11. Add 9mL of complete media to the tissue culture plate 
 
Cell Isolation  
 NIH/3T3 cells were isolated from 100mm tissue culture plates for use in 
experiments according to the following protocol: 
1. Aspirate media 
2. Rinse cells with 5mL DPBS 
3. Aspirate DPBS 
4. Add 3mL of 0.05% trypsin 
5. Incubate for 5 minutes at 37°C 
6. When cells are floating and circular in conformation neutralize the trypsin with 2mL of 
complete media (Table 6) 
7. Transfer the cell suspension into a 15mL conical tube, and remove 50µL for cell 
counting. 
8. Centrifuge the cells at 200g for 10 minutes to form a pellet 
9. Aspirate the media from the pellet and re-suspend in desired amount of complete 
media based on cell counting calculations 
10. Use the cells as needed for the experiment 
 
4.5.2. Hydrogel Protocols and Preliminary Data 
Prior to selecting a hydrogel to perform the final test with, the team ran experiments 
with three hydrogel kits, Extracel (Glycosan Biosystems Inc.)  HyStem-HP, and HyStem-C 
(Sigma Aldrich). The various studies, outlined below, were done to determine the 
compatibility of the hydrogels for our testing purposes. These preliminary experiments 
verified that all gels were compatible for our experimental purposes.  
Gelation Study 
The team performed a study to determine how short the gelation time for the 
Extracel Kit could be without interfering with cell viability. In the scope of this project, the 
solution needs to be able to gel before the PVA mold degrades. The components of the 
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Extracel Kit are Gelin-S, Glycosil, and Extralink. Gelin-S is a thiol-modified gelatin, Extralink 
is a thiol-reactive crosslinker, and Glycosil is thiol-modified sodium hyaluronate. According 
to Glycosan Biosystems Inc., if medium is added to the samples, gelation time will increase. 
If the ratio of components is altered, or the pH is changed, gelation time can be 
manipulated. Specifically, if the ratio of Extralink to Glycosil and Gelin-S increases, the 
gelation time should decrease. Because these molds will be used in the body, changing the 
pH is not feasible for the purpose of this project as it will impact cell viability. Based on 
published data that can be seen in Table 7 below, the team performed several experiments 
to test different ratios of the components.  
 
Table 7: Published data on Gelation time (Extracel™ and Extracel™-HP Gelation Time 
Variation, Glycosan Biosystems Inc., 2011) 
Glycosil (mL) Extralink (mL) Extralink Vol Gelation (min) 
0.5 0.063 8 16 
0.5 0.125 4 11 
0.5 0.250 2 9 
 
 To perform this study, the team reconstituted the hydrogel according to the 
Glycosan Biosystems Inc. protocol (Appendix B), stopping at step 5. The team combined the 
solutions into microcentrifuge tubes in different ratios according to Tables 8 and 9 below. 
The solutions prepared according to Table 8 were made without media, and the solutions 
made according to Table 9 included media. A constant 1:1 ratio of Gelin-S to Glycosil was 
used because Gelin-S is unable to form a gel on its own.  Once the solutions are prepared, 
50 l drops were placed on a tissue culture plate to time until gelation occurred. The team 
defined gelation as the point at which if the outer edge of the gel droplet was pulled back 
with a micropipette tip and released, the gel will retract back into its original shape.  
Table 8: Gelation Study 1 without Media 
Test Glycosil (μl) Gelin-S (μl) Extralink (μl) Ratio (E:G) 
1 20 20 10 1:4 
2 18.75 18.75 12.5 1:3 
3 16.7 16.7 16.7 1:2 
4 12.5 12.5 25 1:1 
5 8.35 8.35 33.3 1:0.5 
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Table 9: Gelation Study 1 with Media 
Test Glycosil (μl) Gelin-S (μl) Extralink (μl) Medium (μl) Ratio (E:G) 
1 20 20 10 10 1:4 
2 18.75 18.75 12.5 10 1:3 
3 16.7 16.7 16.7 10 1:2 
4 12.5 12.5 25 10 1:1 
5 8.35 8.35 33.3 10 1:0.5 
  
This study was performed a second time (referred to as Gelation Study 2) with 
different amounts of reconstituted solutions. The preparations of these tests are shown in 
Table 10.  
Table 10: Gelation Study 2 
Test Glycosil (μl) Gelin-S (μl) Extralink (μl) 
1 20 20 10 
2 20 20 20 
3 20 20 30 
4 20 20 40 
 
 Upon performing the gelation studies, the team observed the time it took for each 
droplet of Extracel hydrogel to gel. If gelation did not occur within 20 minutes, timing was 
stopped because that data is not useful for this project. The tables (11, 12, and 13) below 
show the results from gelation study 1 without media, with media, and gelation study 2, 
respectively.  
Table 11: Gelation Study 1 without Media Results 
Test Glycosil (μl) Gelin-S (μl) Extralink (μl) Ratio (E:G) Time (min:sec) 
1 20 20 10 1:4 19:30 
2 18.75 18.75 12.5 1:3 9:20 
3 16.7 16.7 16.7 1:2 16:40 
4 12.5 12.5 25 1:1 20+ 
5 8.35 8.35 33.3 1:0.5 20+ 
 
Table 12: Gelation Study 1 with Media Results 
Test Glycosil (μl) Gelin-S (μl) Extralink (μl) Medium (μl) Ratio (E:G) Time 
(min:sec) 
6 20 20 10 10 1:4 17:15 
7 18.75 18.75 12.5 10 1:3 15:30 
8 16.7 16.7 16.7 10 1:2 10:54 
9 12.5 12.5 25 10 1:1 15:30 
10 8.35 8.35 33.3 10 1:0.5 20+ 
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Table 13: Gelation Study 2 Results 
Test Glycosil (μl) Gelin-S (μl) Extralink (μl) Time to gel (min:sec) 
11 20 20 10 18:20 
12 20 20 20 20:00+ 
13 20 20 30 20:00+ 
14 20 20 40 20:00+ 
 
 As one can see from the tables above, trial 2 produced a hydrogel with the lowest 
gelation time (Table 11).  The team was also able to achieve multiple gelation times under 
20 minutes, which is ideal for this project. One problem that was solved with the second 
gelation study was that in trials 4 and 5, 20 l barrier pipette tips were used by accident – 
this did not allow enough of the Extracel solution to be mixed into the hydrogel.  However, 
in general the results were not as expected. Table 14 below published by Glycosan 
Biosystems Inc. displays standard component variations and their corresponding gelation 
times.  
 
Table 14: Glycosil : Gelin-S (Extracel™ and Extracel™-HP Gelation Time Variation, 
Glycosan Biosystems Inc., 2011) 
Glycosil (mL) Gelin-S (mL) Extralink (mL) % Gelin-S Gelation 
(min:sec) 
0.500 0.00 0.125 0 10:00 
0.375 0.125 0.125 25 11:00 
0.250 0.250 0.125 50 15:00 
0.125 0.375 0.125 75 20:00 
 
Thickness Study 
In order to determine how thick the hydrogel can be while still being able to 
accurately view the seeded cells, we performed a thickness study. Different volumes of the 
Extracel hydrogel were placed in a 96-well plate with NIH/3T3 cells seeded onto the 
surface. Each well in the plate had an area of 0.33 cm2.  The team decided to test samples 
with thicknesses of 100 m, 200 μm, 300 μm, 400 μm, 500 μm, 1 mm, and 2 mm on a plate. 
NIH/3T3 cells were then seeded onto the surface of the hydrogel after gelation occurred. 
 To perform this study,  the Extracel hydrogel was reconstituted in coordination with 
the Glycosan Biosystems Inc. protocol (Appendix B). The components were added to each 
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well in the desired volumes according to Table 15, and the gel was allowed to form. 250 μl 
of NIH/3T3 cell suspension in 5 mL media was seeded to the surface of each well, and the 
samples were allowed to culture for one day before they were imaged with a microscope.  
 
Table 15: Thickness study 
Trial Area (cm2) Desired 
Thickness (cm) 
Needed 
Volume (µL) 
Gelin (µL) Glycosil 
(µL) 
Extralink 
(µL) 
1 0.32 0.1 3.20 1.28 1.28 0.64 
2 0.32 0.2 6.40 2.56 2.56 1.28 
3 0.32 0.3 9.60 3.84 3.84 1.92 
4 0.32 0.4 12.8 5.12 5.12 2.56 
5 0.32 0.5 16.0 6.40 6.40 3.20 
6 0.32 1.0 32.0 12.8 12.8 6.40 
7 0.32 2.0 64.0 25.6 25.6 12.8 
 
The images of the cells after one day on culture can be seen below in Table 16. 
 
Table 16: Thickness Study 1 Results 
Thickness Day 1 
100 μm 
 
 38 
200 μm 
 
300 μm 
 
400 μm 
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500 μm 
 
1 mm 
 
2 mm 
 
 
 As can be seen in the images above, the cells were highly confluent after one day of 
seeding. Because of this, we performed this study a second time to improve upon the first 
set of results.  The volumes of each component were minimally changed as the area of the 
96-well plate was recorded incorrectly for the first trial. Table 17 below shows the 
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amounts of each component that were used. An eighth well was used as a control with no 
hydrogel; the cells were seeded directly onto the culture surface. 
Table 17: Volume of Extracel™ Hydrogel Components 
Trial Area (cm2) Desired 
Thickness 
(mm) 
Needed 
Volume (µL) 
Gelin & Glycosil 
(1:1 ratio) (µL) 
Extralink 
(µL) 
1 0.33 0.1 3.30 2.64 0.66 
2 0.33 0.2 6.60 5.28 1.32 
3 0.33 0.3 9.90 7.92 1.98 
4 0.33 0.4 13.2 10.56 2.64 
5 0.33 0.5 16.5 13.2 3.30 
6 0.33 1.0 33.0 26.4 6.60 
7 0.33 2.0 66.0 52.8 13.2 
8 - control 0.33 0 0.00 0.00 0.00 
  
The correct amount of cells to seed was determined by cell counting. It was found that 
a 1 mL suspension of cells had about 222,500 cells, so we used 0.0449 mL of cell 
suspension in addition to 155.1 μl of media to each well to seed 10,000 cells.  The results of 
this study after 1 and 2 days of culture are shown below in Table 18. 
 
Table 18: Thickness Study 2 Results 
Thickness Day 1 Day 2 
100 μm 
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200 μm 
  
300 μm 
  
400 μm 
  
500 μm 
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1 mm 
  
2 mm 
  
Control 
  
 
 At 10,000 cells per well proliferation of the NIH/3T3 cells is evident at 2 days of 
culture. In addition, cells can be viewed at all thicknesses; however viewing is ideal 
between 100 μm and 500 μm. 
Cell Density Study 
NIH/3T3 cells were incorporated into Extracel, HyStem-C and HyStem-HP hydrogels 
at thicknesses of 0.25mm and 1mm at densities of 1,000, 2,000, 5,000, and 10,000 cells per 
well. The experiment followed the protocol outlined below, for the exact amounts of 
various components see the paper section about the 3D Density Experiment. 
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1. Isolate NIH/3T3 cells (see isolating cells protocol) 
2. Reconstitute hydrogel components according to their respective protocols (Appendices 
B, H, and I respectively) 
3. Extract the necessary volume of each hydrogel component using a sterile 3mL syringe 
and 20 gauge needle and put in microcentrifuge tubes 
4. Save the unused reconstituted hydrogel components in -20°C 
5. Add the gel components without the crosslinking agents (Extralink) for each hydrogel 
type to a 96-well plate in 0.25mm and 1mm thicknesses in triplicate (see Table 19 for a 
diagram of where each gel amount should be placed).  
6.  Add the required amount of cells to each well in triplicate (see Table 19 for cell 
densities). Top off the cell suspension in each well with media to bring the total cell 
suspension volume in each well to 50µL 
7. Add Extralink to each well and mix to disperse the cell suspension 
8. Image each well daily to view cell proliferation 
 
Table 19: 3D Density 96-well plate Arrangement  
 1 2 3 4 5 6 7 8 9 10 11 12 
A  
Extracel 
0.25mm 
1,000 1,000 1,000 2,000 2,000 2,000 5,000 5,000 5,000 10,000 10,000 10,000 
B 
Extracel 
1mm 
1,000 1,000 1,000 2,000 2,000 2,000 5,000 5,000 5,000 10,000 10,000 10,000 
C 
HyStem-C 
0.25mm 
1,000 1,000 1,000 2,000 2,000 2,000 5,000 5,000 5,000 10,000 10,000 10,000 
D 
HyStem-C 
1mm 
1,000 1,000 1,000 2,000 2,000 2,000 5,000 5,000 5,000 10,000 10,000 10,000 
E 
HyStem-HP 
0.25mm 
1,000 1,000 1,000 2,000 2,000 2,000 5,000 5,000 5,000 10,000 10,000 10,000 
F 
HyStem-HP 
1mm 
1,000 1,000 1,000 2,000 2,000 2,000 5,000 5,000 5,000 10,000 10,000 10,000 
G 
Control (no 
hydrogel) 
1,000 1,000 1,000 2,000 2,000 2,000 5,000 5,000 5,000 10,000 10,000 10,000 
H - - - - - - - - - - - - 
 
After concluding the cells could be viewed when seeded on the surface of the gel, the 
next step in the preliminary experiments was to incorporate the cells into the hydrogel, 
validate a protocol for cell incorporation, and determine which hydrogel to continue 
conducting research with.  Glycosan Biosystems Inc. and Sigma Aldrich were generous, and 
 44 
provided kits of Extracel, HyStem-C and HyStem-HP to our project team for preliminary 
research. These were the three hydrogels used in this experiment, and the protocol 
followed was the 3D Density Experiment.  
Staining and Extraction of 3D Density Experiment  
 The purpose of this experiment was to determine if the cells in Extracel from the 3D 
Thickness Experiment were alive, and if they could be extracted from the hydrogel. Wells 
B11 and B12 of the 96-well plate were stained with Hoechst and Propidium Iodide at 
concentrations of 0.1mg/mL and 0.5mg/mL. Table 20 shows the wells imaged after 30 
minutes of exposure to the stains.  
Table 20: 3D Density Experiment Staining 
0.1 mg/mL Hoechst/Propidium Iodide 
  
0.5 mg/mL Hoechst/Propidium  Iodide 
  
 
 As can be seen by the images above, the cells were dead. The cause of cell death was 
unknown. In addition to staining the wells, a 10X collagenase/hyaluronase solution made 
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by Glycosan was used. The protocol was adjusted to the volume of the 96-well plate based 
off of the protocol listed in Appendix K. 
 Because the team did not have a tissue culture plate (TCP) with a removable insert, 
the gel could not be removed from the TCP. 200 µL of the diluted enzyme solution was put 
in each well and incubated overnight, and still the gel could not be removed from the well 
using a pipette tip. Based on this, if the team wanted to remove the gel and extract the cells, 
and TCP with a removable tissue culture insert would be needed.   
This experiment showed that all three of the gels performed the same, and we could 
move forward with any of them. We chose to move forward with the Extracel Kit. This 
experiment also revealed a complication with mixing the cells with the hydrogel. We 
observed that mixing the cells with the hydrogels at time point zero, the cells settled to the 
bottom of the plate during the 15-18 minutes of gelation period (Figure 20). Adding the 
cells to gel mixture at a later time point may help avoid this problem.  
3D Cell Dispersion Experiment 
 The purpose of this experiment was to try and achieve uniform 3D cell dispersion 
throughout the hydrogel. To achieve this, we allowed the gel to start crosslinking and then 
added the cell suspension at different time points (0, 4, 8, 12 and 16 minutes of gelation) 
before plating in culture wells. The protocol followed is detailed under 3D Cell Dispersion 
Experiment. As can be seen in Table 21 below, 3D cell dispersion was achieved at all time 
points tested. Addition of cells to the gel after, 8 and 12 minutes of gelation resulted in an 
even distribution of cells. The 3D dispersion is apparent by the inability to focus on all the 
cells simultaneously, but rather having to move through the gel to view all the cells. Based 
on these results, in future experiments the cell suspension was added to the gel between 8 
and 12 minutes post initiation of gelation.  
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Table 21: 3D Cell Dispersion 
Time Post 
Gelation 
Day 1 Day 1 Day 2 
0 minutes 
   
4 minutes 
   
8 minutes 
   
12 minutes 
   
16 minutes 
   
 
 A follow-up to this experiment was to determine if the cells in the 3D dispersion 
were alive and proliferating. After monitoring the gel for 10 days, we observed that the 
cells maintained a spherical conformation, as opposed to the normal fibroblast phenotype 
observed while growing on a 2D tissue culture plastic surface. We believe that this change 
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in phenotype is due to the three-dimensionality of the gel as well as due to a drastic change 
in stiffness that the cells are used to growing immediately prior to the hydrogel. In order to 
assess the viability and proliferative ability of cells, we conducted a BrdU cell proliferation 
assay (Table 22). The BrdU assay followed the protocol in Appendix E. 
Table 22: Staining of 3D Cell Dispersion 
Hoechst BrdU Phase Contrast 
10X 
   
40x 
   
  
As can be seen above, the cells in the gel were alive and proliferating. The 
proliferating cells could be seen as growing in small to large clumps. This is clearly seen in 
the 40X images and is highlighted by boxes focusing on one area of cell aggregation. We 
hypothesize that the change in dimensionality and stiffness resulted in a lag period where 
the cells needed time to accustom to the new environment before starting to proliferate. 
Because the cells are in a 3D environment, cells are now able to grow in all directions to 
form clumps as opposed to a monolayer growth on regular tissue culture plates.  
Hydrogel Selection 
Based on the results of the experiments discussed above, the team determined all 
three hydrogels (Extracel, HyStem-C, and HyStem-HP) to be compatible for the final test. As 
such, the team decided to move forward with Extracel for the duration of the experiment.   
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4.5.3. Material Degradation Study 
 In order to assess the degradation rate and the factors that affect water-soluble PVA 
and PLA degradation, we developed a protocol that is described below. Three one inch long 
sections of each 1.75 mm filament were cut off of the material stock and were immediately 
used in each experiment. 
 The main factor that will effect degradation is the media or water that it is dissolved 
in. Each set of filaments were placed in individual beakers containing 10 ml of water or 
complete DMEM media. The water and media were assessed at room temperature (21°C) 
and in an incubator at 37°C. The degradation rate was carefully monitored in 15 minute 
intervals until the filaments had dissolved.   
 Factors that could influence the degradation rate are ultra-violet (UV) light and 
oxygen. For these factors three filaments from each material class were placed in an 
incubator under germicidal (UV) light for five days. Alternatively oxygen effects were 
measured by placing the filaments in an open container exposed to the atmosphere.  
 After a period of two hours the PVA filaments in both temperatures and solvents 
(water and DMEM) had dissolved. From recording data at each 15 minute time point it was 
determined that DMEM media at 37°C was the optimal method for degrading the PVA. PLA 
showed minimal to no degradation in either solvent at any temperature. Neither oxygen 
nor UV light affected the degradation rate significantly after the two hour period. A note 
made by the team was that movement of the solvents also sped up the degradation time. 
The rotation or movement of the solvent is key in a clean dissolution of PVA.  
 From these results it was determined that PVA degrading in DMEM media in a 37°C 
incubator was the fastest option for material degradation. Rotation of the media can be 
achieved by a rotator plate or a shaker that can be used in an incubator. 
4.5.4. 3D Printer Protocols and Preliminary Data 
A variety of tests and file processing methods had to be established in order to 
achieve consistent print quality and fractal reproduction from the MakerBot Thing-O-Matic 
printer. These methods will be detailed in the following sections. They were vital in 
ensuring that the Thing-O-Matic was capable of printing fractal structures at a small scale 
that are otherwise on the very edge of its capabilities as a 3D printer. This is especially the 
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case with PLA and PVA, which are considered experimental materials for the Thing-O-
Matic. 
Test Prints 
To achieve the best print quality and reproduction possible, the Thing-O-Matic must 
be properly calibrated. First, the extruder tip and build platform positions were calibrated. 
The ReplicatorG software has a built-in script named Calibration. When run, this script asks 
the user to manually center the build platform, and then positions the extruder tip in the 
middle of the platform and just barely above it. Once done, the printer saves this position as 
the zero point. This calibration was performed before each day of printing. Because the 
.GCODE files that contain the code for each 3D object printed are generated based on this 
zero position, each of those files had to be regenerated every day to ensure optimal print 
quality. 
Next, the printing accuracy had to be properly calibrated. This was performed by 
printing a 20 mm x 20 mm x 20 mm solid cube of ABS, then measuring it with precision 
digital calipers. The X, Y, and Z axis motor revolutions per mm were then adjusted to 
ensure that the 20 x 20 x 20 mm cube was accurately reproduced. This calibration was 
performed after the printer tip had been serviced and when the printer filament material 
was changed, first to PLA then to PVA.  
It is important to note that the Thing-O-Matic, as a low-cost, early generation 3D 
printer initially designed for ABS printing only, is incapable of fully reproducing each 
fractal shape accurately each time to a very fine degree of detail, even with calibration. 
However, it serves its purpose as a proof of concept device. Newer generations of 3D 
printers at the same price range as the Thing-O-Matic deliver significantly better quality 
and reproducibility, so even better results are possible. It is worth noting that any 
inaccuracies or variation in the printing of the 3D fractal .STL files impose a sense of 
randomness to the fractals being printed. This randomness is a feature of fractals found in 
nature, which are categorized as plasma fractals. Thus, printing inaccuracies actually 
contribute to the effectiveness of each fractal mold shape and may even provide extra 
pores in which cells may adhere and additional channels through which nutrition can be 
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delivered. The resulting prints are not only fractal in nature, but they incorporate more 
biomorphic features because of these slight irregularities.  
Final .STL Processing and .GCODE Generation 
The process of converting the fractals into molds, then producing .STL and finally 
.GCODE files requires significant computational power and a number of steps. First, the 
generated fractal shapes are opened as Mesh files in SolidWorks using the ScanTo3D 
function. Then, an assembly is created with the generated fractal shapes and the mold shell, 
shown below in Figure 12. The outer dimensions of this shape are 20 mm x 20 mm, the 
inner dimensions of the space are 15 mm x 15 mm, and the walls are 2.5 mm thick. The 
fractal was then placed within this mold, and the entire assembly was exported as a single 
.STL file using SolidWorks.  
 
Figure 12: The base mesh for the fractal molds. Also used as the control. 
 
Limitations in the SolidWorks .STL export script resulted in initial files that did not 
print correctly through ReplicatorG. These files were uploaded to the Netfabb Cloud 
Service (cloud.netfabb.com) which is an automated .STL repair utility. In addition to 
repairing the .STL files, this service provided surface area and volume values for each 
fractal mold. The resulting .STL files were opened with ReplicatorG 0037 and exported to 
the .GCODE format using Skeinforge 50 that was built into the ReplicatorG software. The 
.GCODE files were then printed normally using the Thing-O-Matic. 
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Because of the lengthy processing steps required to import a fractal mesh into 
SolidWorks and the file size and processing time limitations in the Netfabb service, the 
types of fractals that could be used were limited. Fractals chosen could not be too complex, 
and could not have excess amounts of detail or large recursion indexes (n > 3). This was not 
an issue for us due to the resolution limitations of the Thing-O-Matic, but it will be a 
limitation in the future if more capable 3D printers are utilized.  
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Chapter 5. Final Design and Validation 
5.1 Conceptual Final Design 
The selection of the final design was based on the design’s ability to achieve all of the 
previously stated constraints, objectives, and functions. This achievement was evaluated on 
various levels from binary, to a numerical range between 1 and 100. These multiple 
evaluations produced a numerical score for each design. The highest scoring design was 
selected for further development.  
5.1.1. Fabrication Method Selection  
The following tables and charts describe how we selected our final fabrication 
method. First, we used our Functions/Means tree to develop the Functions/Means Matrix, 
shown below in Table 23. This relates the functions to each design alternative.  If the design 
achieves the function in that row, the means by which it does so are written. This 
eventually determined how successful we believed each design could be.  
Table 23: Functions/Means Matrix 
 
Next, we created a matrix relating each design to the constraints that we previously 
specified. Table 24 below shows this matrix. It is a binary system displaying a ‘Y’ if the 
design meets the specified constraint and an ‘N’ if it does not. As shown, the embedded cells 
design does not meet all of our specified constraints. The resources needed to create a 
scaffold of this nature are beyond the scope of our project and the material would not be 
Functions Printed Scaffold Hydrogel Mold Sacrificial Lattice Embedded Cells 
Must Not Develop 
Necrotic Core 
Fractal Geometry, 
Controlled 
degradation of 
scaffold 
Fractal geometry, 
surface 
characteristics for 
soft tissues 
ECM/Surface 
characteristics, 
fractal geometry, 
controlled 
degradation of 
scaffold 
ECM/growth 
factors 
incorporated 
Maintains Cell 
Viability 
All All All All 
Even Flow of 
Nutrients 
Submerge in media 
Submerge in media, 
porosity 
Submerge in media Submerge in media 
Mimics Biological 
Structure 
Fractal geometry, 
material, Surface 
Area : Volume 
Fractal geometry, 
Surface Area : 
Volume 
Fractal geometry, 
Surface Area : 
Volume 
Surface Area : 
Volume 
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compatible with the MakerBot Thing-O-Matic 3D printer. At this point, we went ahead with 
the three designs that did meet all of our constraints. 
 
Table 24: Matrix of Design Constraints 
Constraints Printed Scaffold Hydrogel Mold Sacrificial Lattice Embedded Cells 
Manufacturability Y Y Y N 
Biocompatible Y Y Y Y 
Resorbable Y Y Y Y 
Within Budget Y Y Y Y 
MakerBot 
Compatible 
Y Y Y N 
Size Limitation Y Y Y Y 
Time Limit (28 
Weeks) 
Y Y Y Y 
 
 
Next, we created a Pairwise Comparison Chart (PCC), as shown in Table 25, 
comparing the functions of our project. We determined that cell viability and the lack of a 
necrotic core were equally the most important functions of our design. In ranking the other 
functions, even nutrient flow was next, followed lastly by mimicking a biological structure.  
 
 
Table 25: Pairwise Comparison Chart of Design Functions 
 Must not 
develop a 
necrotic core 
Maintains Cell 
Viability 
Even Nutrient 
Flow 
Mimics 
biological 
structure 
 
Totals 
Must not 
develop a 
necrotic core 
 
0.5 1 1 2.5 
Maintains Cell 
Viability 0.5 
 
1 1 2.5 
Even Nutrient 
Flow 0 0 
 
1 1 
Mimics 
biological 
Structure 
0 0 0 
 
0 
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Finally, we created a weighted matrix of our design alternatives to determine which 
fabrication method would best fit our project. The multipliers were determined based on 
the PCC. Then, each function for each design was given a score between 0 and 100 based on 
the information presented in our Functions/Means Matrix in Table 26. The scores were 
initially arbitrary, but then became subjective relative to the other alternative designs.  
 
Table 26: Function/Means Matrix 
Functions Printed Scaffolds Hydrogel Mold Sacrificial Lattice Embedded Cells 
Must Not Develop 
Necrotic Core 
Fractal Geometry, 
Controlled 
degradation of 
scaffold 
Fractal geometry, 
surface 
characteristics for 
soft tissues 
ECM/Surface 
characteristics, 
fractal geometry, 
controlled 
degradation of 
scaffold 
ECM/growth 
factors 
incorporated 
Maintains Cell 
Viability 
All All All All 
Even Flow of 
Nutrients 
Submerge in media 
Submerge in media, 
porosity 
Submerge in media Submerge in media 
Mimics Biological 
Structure 
Fractal geometry, 
material, Surface 
Area : Volume 
Fractal geometry, 
Surface Area : 
Volume 
Fractal geometry, 
Surface Area : 
Volume 
Surface Area : 
Volume 
 
 
As can be seen in Table 27, all three of the evaluated designs are feasible options; 
however, the hydrogel mold is the best option. In addition to the features displayed in the 
previous tables, the hydrogel mold is also a unique attempt at solving this problem with a 
3D printer. The hydrogel mold will also allow a variety of cell type options because its 
mechanical characteristics are similar to that of biological tissue. In addition, this provides 
more material options outside of PVA and water-soluble PLA, the only two materials both 
biologically and MakerBot-compatible.  
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Table 27: Weighted Design Matrix 
Functions Printed Scaffold Hydrogel Mold 
Sacrificial 
Lattice 
Embedded Cells 
Must Not 
Develop 
Necrotic Core 
(X 2.5) 
90 = 225 100 = 250 95 = 237.5 X 
Maintains Cell 
Viability 
(X 2.5) 
100 = 250 100 = 250 100 = 250 X 
Even Flow of 
Nutrients 
(X 0.75) 
75 = 56.25 90 = 67.5 70 = 52.5 X 
Mimics 
Biological 
Structure (X 
0.25) 
80 = 20 80 = 20 65 = 16.25 X 
TOTAL: 551.25 587.5 556.25 X 
 
The hydrogel mold will require further verification testing before being pursued in 
testing validation. These verifications include specifically the ability of the hydrogel to 
maintain the selected geometric structure after the mold dissolves.  
5.1.2. Fractal Classification and Generation 
The MathWorks Matlab computational software package was used for the 
classification and generation of 3D fractals for this project. The classification and 
generation algorithms used are a combination of original programming and code from the 
Matlab Central File Exchange (www.mathworks.com/matlabcentral/fileexchange). The 
entire system will be detailed below, including code samples and licensing information. 
The basic program design is outlined in Figure 13 below. The user is first presented 
with an opening screen that asks the user to either Generate Fractals or Classify Fractals. If 
the user chooses to generate a fractal, they are taken to a window that allows them to select 
from any of the fractal generation algorithms that are available. Upon choosing an 
algorithm, the user is taken to a window that allows for input of any of the parameters 
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available in the fractal generation script and a button that generates a .STL file of the 3D 
fractal that can then be imported into ReplicatorG and printed with the MakerBot Thing-O-
Matic 3D printer. When available, the user will also be supplied with some of the default or 
common parameters that can be used with each algorithm. If the user chooses to classify a 
fractal, they are taken to a window that allows them to upload three images of the fractal: 
Top, Front, and Right. The user may then generate a report that classifies the fractal by 
lacunarity (L) or by fractal dimension (D).  
 
 
Figure 13: Flow Chart of Fractal Generation and Classification Program in MatLab. 
See Appendix C for code. 
 
The user interfaces with the fractal generation and classification software by way of a 
Graphical User Interface (GUI) written using the MatLab GUIDE utility. An example of the 
user interface can be seen below in Figure 14. This GUI utilizes buttons, scrolling lists, and 
selection boxes because they are common interface elements in modern software packages, 
thus improving the inherent ease of use in this software.  
 
Program Launch 
/ Selection 
Screen 
Generate 
Fractals 
Xenophyophore 
Bifurcating 
Fractal Tree 
Honeycomb 
Structure 
Coral 
Spiral 
Classify Fractals 
Upload Images 
(x3) 
Lacunarity 
Mass Fractal 
Dimension 
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Figure 14: Function Selection Screen 
 
The window for the fractal classification section of the program can be seen below in 
Figure 15. The two available classification tests are lacunarity and fractal dimension. Three 
images are uploaded for each test – one image of the top, one image of one side, and one 
image of another side turned 90 degrees. Each image should be 1000 px x 1000 px in size. 
The chosen algorithm will be run on each of the images and the results for each image will 
be averaged together to achieve a 3D fractal score for each parameter. The fractal 
dimension and lacunarity algorithms used were found on the MathWorks File Exchange, 
and are available for use under Appendix L.  
 
 
Figure 15: Fractal Classification Window 
 
 
 The four fractal geometries chosen for the first round of testing, as well as many 
other geometries considered, were generated with either MathWorks Matlab or Incendia 
software packages, or modeled directly within SolidWorks. As part of the initial research 
 58 
stage, a fractal generation algorithm was written which can be used in a general sense to 
generate iterated function systems for any base shape if provided with coordinates. 
 The general fractal generation algorithm which was written for this project is 
presented in Appendix C, though most fractals generated with this algorithm were not 
tested due to equipment limitations in the Makerbot Thing-O-Matic 3D printer. All code is 
written for MathWorks MatLab. 
 This algorithm can be used with any set of vertices and faces defining a 3D seed 
shape for the fractal. The program outputs a 3D plot of the target geometry which can then 
be exported using a Matlab to .STL conversion program. Many different geometries were 
tested with this algorithm, but the only ones generated that were used in final testing were 
the Sierpinski triangle and Menger Sponge (cluster fractal), using triangle and cube base 
shapes, respectively.  
 A bifurcating fractal tree is one of the most simple fractal shapes, yet it can model 
some of the most complex biological phenomena, including vasculature and neural 
networks. Due to its simplicity, the bifurcating tree that we used was manually modeled 
directly in Dassault Systemes SolidWorks.  
 The most geometrically complex fractal used for this project was the fern fractal. 
This fractal was an experiment in using more complex fluid surface shapes, rather than 
stricter geometries, while maintaining self-similarity at different levels. Due to its 
difference from the other shapes we considered, the above algorithm was insufficient, so 
the Incendia software package was used. Incendia is a program that can generate complex 
fractal shapes given any user defined base shapes and algorithms, then output them as .STL 
files.  
5.1.3. Fractal Selection 
The fractal geometries that were selected for testing were chosen based on 
optimization of surface area to volume ratio, integration of biomorphic design, and ability 
to be printed using the MakerBot Thing-O-Matic. Four of the most promising fractal 
geometries that could be successfully and rapidly (<30 min) printed using the Thing-O-
Matic in both PLA for prototyping and PVA for testing were selected.  
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The first fractal selected was the Menger sponge, a fractal in the Cluster fractal 
category. This fractal is built by starting with a cube and iteratively subtracting smaller 
cubes from the larger one, increasing the surface area to volume ratio. This also forms a 
self-similar model. Iteration of the generation algorithm can be carried out as many times 
as desired, producing increasingly better surface area to volume ratios. This is limited by 
the capabilities of the Thing-O-Matic printer to n=2 or n=3. A cross-section of the Menger 
Sponge that will be used in our experimental testing can be seen below in Figure 16.  
 
Figure 16: Menger Sponge Fractal Cross-Section 
 
 Another set of fractal systems that were explored are Iterated Function Systems 
(IFS). These fractal geometries are biomorphic in nature because they mimic some 
common biological shapes – such as plant leaves, roots, and branches, blood vessels, and 
neural networks. Any function may be iterated to create such a 3D structure, but the two 
specific ones chosen were a tree and a fern. Figure 17 is an IFS fractal model of a fern, 
which was chosen to model the nutrient transfer that occurs in plants. Figure 18 is an IFS 
fractal of a bifurcating tree, designed to model tree roots and branches in a simplified 
mathematical manner.   
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Figure 17: An Iterated Function System Fractal Modeling a Fern 
 
 
Figure 18: A Bifurcating Fractal Tree 
 
The final fractal chosen for testing is the Sierpinski triangle. This is a simple variation 
on the Menger sponge in that it is also a cluster fractal. It is generated using the same 
algorithm as the Menger Sponge, but using a pyramid as the base shape instead of a square. 
This fractal is designed to optimize surface area to volume in much the same way as the 
Menger sponge and, if this category proves successful in testing, many other primitive 3D 
shapes could be processed with the same algorithm to potentially generate additional 
effective geometries. An example of the Sierpinski triangle in 3D can be seen below in 
Figure 19.  
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Figure 19: Three-Dimensional Sierpinski Triangle Fractal Shape 
 
5.2 3D Printing of Fractal Molds 
The 3D printing protocol for all fractal molds produced in PVA was determined then 
kept consistent to ensure reproducibility of mold quality and comparability of results. The 
MakerBot Thing-O-Matic printer was equipped with a Heated Build Platform covered with 
Blue Painter’s Tape, though the heated platform was powered off for PVA printing. The 
printer was kept in a Plexiglas enclosure that was mostly sealed using tape. A Nitrogen 
purge of the enclosure was performed prior to printing, and a steady flow of Nitrogen was 
maintained during printing to lower the humidity in the print environment.  
Printing was conducted at room temperature (22ᵒ C) with the extruder tip set to 210ᵒ 
C. Fractal molds were printed at 50% infill, 0.3mm layers, 1 shell, with a raft, at 20mm/s 
plastic extrusion speed. Each fractal mold was printed three times per test, and the 
resulting documents were sterilized in 70% ethanol and UV light.  
5.3 Surface Area to Volume Ratio Calculations 
An essential part of our data analysis was a comparison of the surface area to volume 
ratios of each fractal we used and the resulting cell growth in each one. The following 
describes how we calculated the surface area to volume ratios of the resulting gel using 
data from the fractal molds.  
As part of the .STL generation process, each file was submitted to the Netfabb Cloud 
Service (cloud.netfabb.com) that repairs submitted .STL files and provides the Surface Area 
and Volume of the mold geometry. Using this service, we obtained a set of numbers from 
which we calculated the surface area and volume of the gel fractals themselves. We also 
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used the amount of gel added to each scaffold as a starting point. The full set of data for 
each scaffold is included below in Table 28. 
Table 28: Surface Area and Volumes for Fractal Molds and Hydrogel 
Fractal Mold Name Surface Area (cm2) Volume (cm3) Volume of Gel (cm3) 
Control 16.60 1.67 1.03 
Cluster 22.95 1.89 0.50 
Fern 20.11 1.84 0.58 
Sierpinski 17.39 1.71 0.40 
Tree 21.2 1.80 0.90 
 
The surface area to volume (SA:V) ratio was an essential metric that we used to 
classify the theoretical effectiveness of a fractal shape to provide nutrition to cells in a 
tissue scaffold.  Basic values used in the calculation of the SA:V ratio were calculated by 
submitting the fractal scaffold .STL files to the online Netfabb Cloud Service, which repairs 
.STL files and provides the surface area and volume of the model. The following values 
computed by the program were used: 
                                                   (    ) 
                                          
 
The following values were constants for each fractal mold: 
                                         
                                  
                                  
 
Where the height was determined based on the volume of hydrogel added to each 
mold, in the following manner: 
                          
                          
        
      
        
 
 
Thus, the surface area of only the fractal geometry surface in each mold can be 
defined as: 
          (                   )                      
 
 
 63 
And the surface area of the full hydrogel scaffold generated from the mold can be 
represented by: 
                                                   
 
This method was used to find the surface area and volume of each gel tissue scaffold, 
and then compute the surface area to volume ratios of the resulting hydrogel tissue 
scaffolds. The final values for each scaffold are presented below in Table 29. 
 
Table 29: Surface Area, Volume, and SA:V Ratio for all hydrogel scaffolds 
Scaffold Name Surface Area (cm2) Volume (cm3) SA:V Ratio (cm-1) 
Cluster 12.77 0.50 25.5 
Fern 20.11 0.58 17.2 
Sierpinski 17.39 0.40 16.2 
Tree 11.85 0.90 13.2 
Control 7.24 1.025 7.06 
5.4 Hydrogel Protocol 
The final step that needed to be completed before creating the scaffolds was to 
calculate the amount of cells to be seeded within each scaffold. From previous studies it 
became apparent that the cells would need to have quite a high density because they are in 
3D conformations. The team found previously that the cells did not grow and proliferate as 
fast within the gel as they typically do on tissue culture plate surfaces. This may be 
attributed to the fact that they are not as close together so they cannot communicate 
through chemical signals or factors as well as they can on 2D surfaces, in addition to a 
lower stiffness than TCP.  
Based on observations and suggestions from the team’s advisor, it was determined 
that the scaffolds should be seeded with cells at a density of 10,000 cells per monolayer. In 
the case of NIH/3T3 cells, a monolayer is 20 μm thick, because NIH/3T3 cells are normally 
18 μm in size (Invitrogen, 2013). The number of monolayers was determined by measuring 
the approximate thickness of the mold. From this information, we extrapolated the number 
of cells needed per mold. Information for the volume of the gel components of each mold, 
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the total volume, the number of monolayers, the area of an entire cross section, the 
thickness, and the number of cells to be seeded are presented below in Table 30.  
 
Table 30: Volume of Gel and Cell Density Components of Scaffolds 
Fractal 
/Mold 
Volume 
(μL) 
Volume of 
Glycosil and 
Gelin-S (μL) 
Volume of 
Extralink 
(μL) 
Area 
(cm2) 
Thickness 
(μm) 
Number of 
monolayers 
Total # of cells 
Cluster 500 400 100 2.25 2220 111 1,110,000 
Fern 580 464 116 2.25 2580 129 1,290,000 
Sierpinski 400 320 80 2.25 1780 89 890,000 
Tree 900 720 180 2.25 4000 200 2,000,000 
Control 1025 820 205 2.25 4560 228 2,280,000 
TOTALS  2724 681    7,570,000 (X3) 
 
Once the calculations for cell densities were complete, printing of the molds began. 
The molds were printed in polyvinyl-alcohol (PVA) inside a closed Plexiglass printer 
enclosure after a nitrogen purge was performed. A total of 15 PVA molds (3 of each of the 
following fractals: cluster, fern, Sierpinski, tree, and control) were printed. The molds were 
rinsed under a hood in 70% isopropyl alcohol for less than 10 seconds. The molds were 
then placed in weigh boats and exposed to ultraviolet light for 20 minutes for sterilization 
before the hydrogel was added.  
While the molds were being printed, volumes of each hydrogel and cell suspensions 
were prepared for each mold in microcentrifuge tubes. Once the molds were sterilized and 
the gel components prepared, Extralink, Glycosil, and Gelin-S were combined for an 
individual mold. After waiting for 8 minutes, the volume of cell suspension and any 
additional media calculated in Table 31 was added into the molds. The cell suspension 
contained 2,280,000 cells / 0.5 mL. The components were mixed via pipetting before being 
added to each mold. While waiting for each mold to set, more molds were prepared until all 
15 were complete. For a detailed outline of this protocol, see Appendix J. 
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Table 31: Final volumes of gel components and cell suspension. 
Mold 
(Fractal) 
Gelin-S & 
Glycosil (μL) 
Extralink 
(μL) 
Cell 
Suspension 
(μL) 
Additional 
Media (μL) 
Cluster 400 100 48.7 51.3 
Fern 464 116 56.6 43.4 
Sierpinski 320 80 39.0 61.0 
Tree 720 180 87.7 12.3 
Control 820 205 100.0 0 
 
5.5 Cell Maintenance Protocol 
After the molds had sufficiently gelled, they were placed in 100 mm tissue culture 
plates with 50 mL of DMEM and placed on a rotator inside of an incubator. Four hours 
later, the media was aspirated to remove as much dissolved PVA as possible, and replaced 
with 45 mL of new DMEM before returning the plates to the rotator. The following day, 
after the majority of the PVA had dissolved, the molds were removed from the 100 mm 
tissue culture plates, and placed in 30 mm tissue culture plates with 10 mL of media. Each 
successive day, half of the media was aspirated and replaced with new DMEM. The only day 
that this did not occur was on the fourth day of culture. On the fourth day, the molds were 
rinsed in media by submersion and transferred to new 30 mm tissue culture plates with 10 
mL of fresh growth media. During every day of culturing, phase contrast microscopy 
photographs were taken until the samples were fixed for histology on day 16.  
5.6 Hydrogel Transfer and Washing 
The day after the hydrogel scaffolds were molded, and on the fourth day of culture, 
we replated the scaffolds to ensure that there was as little PVA left in and around the 
scaffolds as possible. In order to do this, each mold was washed by submersion in DMEM. 
Polypropylene flexible spatulas were sterilized and used for picking up, rinsing, and 
replating the hydrogel. A photograph of the rinsing setup may be seen below in Figure 20.  
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Figure 20: Setup of Scaffold Rinsing on Day 4 of Culture 
5.7 Cell Imaging 
After the hydrogel scaffolds were created, phase contrast images were acquired every 
day for 16 days of culture at 10X magnification using a Zeiss Axiovert 40 CFL inverted 
fluorescent microscope. During the first 2-3 days of culture, it was difficult to visualize any 
cells because of the presence of PVA in the mold. After a week to 10 days in culture and 
removal of PVA, cells were more visible as evidenced by formation of cell clusters.  
5.8 Cell Fixation and Sectioning Protocol 
On day 16 of culture, the hydrogels were fixed and prepared for cryostat sectioning 
on the Leica CM3050 Cryostat Microtome (see Appendix F for the SOP) following the 
procedure outlined below.  
1. Immediately after the experiment is over, place the hydrogel tissue scaffolds 
into individual cassettes and label with the appropriate identifying data. 
2. Fix the hydrogels using methanol-free formaldehyde (this is to allow for actin 
staining) in a volume 10-15 times greater than that the specimen for 4-8 
hours.  
3. Wash your specimen under running tap water for 10 minutes. 
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4. Place the cassettes into freshly made 30% sucrose solution (100mL DI Water, 
and 30.0g of sucrose) in a leak proof container. 
Just prior to beginning sectioning, the samples were placed under running water for 
10 minutes. The samples were then attached to a chuck using optimal cutting temperature 
(OTC) compound. The hydrogel was cut in 20 micron sections, taking 16 sections from the 
top portion of the gel, 32 sections from the center of the gel, and 16 sections from the 
bottom of the gel. After completion of sections, the OTC was dissolved, the hydrogel was 
placed back in its cassette, and into 100% ethanol for storage. 
5.9  Cell Staining Protocols 
Two staining procedures were performed on select slides containing cryostat 
sections - hematoxylin and eosin (H&E) and AlexaFluor 488-Phalloidin with DAPI as 
counter-stain. H&E staining followed the procedure in Appendix G and stained the nuclei 
and cytoplasm. The AlexaFluor and DAPI staining followed the protocol outlined below, 
and stained for the actin cytoskeletal structure and alignment, and nuclei respectively. 
Before beginning the actin staining procedure, slides to be stained were placed on a test 
tube rack with paper towel beneath it. Between each step pour off the respective liquid, 
and then gently shake off the excess before proceeding to the next step.  
1. Rinse the slides twice with 1mL DPBS+. Each rinse lasting 5 minutes.  
2. Add 1mL 1% BSA blocking solution. Incubate at room temperature for 10 
minutes.  
3. Rinse twice with 1mL DPBS+. 
4. Add 500µl of AlexaFluor 488-Phalloidin. Incubate at room temperature for 20 
minutes. 
5. Rinse twice with 1mL DPBS+. 
6. Counterstain using 1mL of 200ng/mL of DAPI. Incubate at room temperature 
for 10 minutes.  
7. Rinse twice with 1mL DPBS+. 
8. Mount the slides with a coverslip using Cytoseal.  
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Chapter 6. Design Verification 
After the final experiment was executed following the protocols outlined above, the 
results of microscopy, histology, and staining were analyzed to determine if the experiment 
was successful. While there was no way to quantify the number of cells, analysis of the 
images showed that the cells remained in a 3D conformation within the hydrogel for the 
entirety of the experiment.   
6.1 Cell Images Over Time 
All hydrogels were reviewed and imaged daily to monitor the degradation of the PVA 
(black spots/regions on the images in Table 32), and the state of the cells. The cells were 
closely monitored for the initiation of proliferation. As can be seen by the formation of 
clumps, proliferation was visible on day 10 of culture (Table 32). The formation of clumps 
confirmed the cells were alive and adjusting to the 3D hydrogel environment. The length of 
time for proliferation to start could be attributed to the cells adjusting to the mechanical 
properties of the hydrogel, which is much softer than a TCP, and also adjusting to the 
distance with regards to cell-to-cell communication.  
Table 32: Microscopy Images of Hydrogels from Days 5, 10, and 16 
Hydrogel 
/Day 
Day 5 Day 10 Day 16 
Cluster 
   
Fern 
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Sierpinski 
   
Tree 
   
Control 
   
6.2 Cell Viability / Histology Results 
Histology was performed to view the middle of the hydrogel. The gels were prepared 
as outlined in Section 5.8, and the depth of the sections taken was based on the number of 
cuts made. The sections were 20 µm in thickness, and the depth was counted starting when 
the hydrogel was first cut with the blade. Unfortunately, there was no way to make the 
hydrogel completely level on the chuck. Sections from the top, middle, and bottom were 
taken. In addition, some of the hydrogels cut more cleanly than others, some formed 
crystals, and disintegrated when coming in contact with the blade. This occurred with the 
tree fractal in particular. Despite these difficulties, we were able to obtain clean histological 
sections for staining and further analysis.  
A portion of the slides were stained with H&E to view the nuclei (purple) and 
cytoplasm (pink). As can be seen in Figure 21, cells could be visualized at various depths, 
distributed uniformly as a 3D construct. The hydrogel (mesh-like structure stained purple) 
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is holding the cells in place; the nuclei in the foreground are dark purple circles, and 
cytoplasm can be seen in the background as light pink circles. This section of the Fern mold 
was 1500 µm deep, in the middle of the scaffold. This image confirms the presence of cells 
in the middle of the gel, validating our procedure.  
 
 
Figure 21: H&E staining of fern section 
 
A few sections were stained with AlexaFluor-488 conjugated phalloidin (AF) to stain 
the actin cytoskeleton and counterstained with DAPI for staining the nuclei. Upon viewing 
the slides stained with AF and DAPI, multiple tube-like structures were identified in the 
Sierpinski and cluster gels, and at least one was found in the tree and fern gels. 
Representative images of these structures from the cluster gel at a depth of 1200 µm are 
shown in Figure 22 below. As can be seen by the images, the cells are clearly aligning in an 
organized structure that includes branching (bottom rows). This discovery was 
unexpected, but promising. The cells formed these structures in approximately 6 days 
(proliferation started on day 10 of culture, and the gels were fixed on day 16), and at 
depths of approximately 1200 microns from either end of the scaffold. Such formations 
were also found in the control gels at about the same depth. However, as can be seen in 
Figure 23, the organization of the structures in control is not as robust as the fractal 
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scaffolds. The majority of the control gels had single scattered cells as can be seen in the 
image in Figure 24.  
 
Figure 22: Actin (left) and DAPI (right) staining of tube-like formations in cluster 
section (40X top and bottom, 20X middle) 
 
  
Figure 23: Actin (left) and DAPI (right) of cell clusters in control section (32X) 
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Figure 24: Actin (left) and DAPI (right) of cells in control section (20X) 
 
6.3 Confocal Microscopy Results 
With the discovery of tube-like formations, the actin stained sections were subjected 
to confocal microscopy on the cluster gel in attempts to further validate their identity. 
Confocal microscopy showed that the structures transcended the entire 20 µm thickness of 
the section, proving they are 3D. Figure 25 shows a portion of a tube-like structure in the 
cluster gel. This image more clearly shows the cytoskeletal alignment (green) of the cells. 
Further testing is required to confirm the identity of these structures. 
 
 
 
Figure 25: Actin and DAPI stain at 63X and 1.8 zoom of tube-like formation in cluster 
section 
 73 
Chapter 7. Discussion 
This chapter discusses the specific aims that were met throughout the project, 
including all of the manufacturing aims and limitations, the hydrogel scaffold and cell 
incorporation data, and how the process of the manufacturing and testing our final design 
went. 
7.1 Review of Raw Data 
Imaging the cells over time enabled us to see the proliferation and alignment of the 
NIH/3T3 cells. The aggregation of cells seen on day 10 of the images signifies that not only 
are the cells alive, they are proliferating. Also, the appearance of the cell aggregates can be 
seen at all depths of the scaffold, meaning that cells that are not immediately exposed to the 
media are surviving and growing.  While the proliferation of the cells is slower than 
expected, complete media with the addition of growth factors could speed up the process.  
The validation of our cell incorporation method was evident in the H&E stained 
hydrogels. The existence of cells in the middle of the gel confirms that cells remained 
suspended in the gel over an extended period of time and did not settle to the bottom of the 
scaffold.  
The unexpected result of tube-like formations in the histological sections of the 
cluster, Sierpinski, fern, and tree fractals follow the premise that the scaffolds with high 
surface area to volume ratios will exhibit more cell growth than scaffolds with low ratios, 
such as the control slab. While the identity of the alignments are unknown at this time,  the 
presence of these structures in multiple areas throughout the Sierpinski and cluster 
scaffolds rule out any procedural error or random effect. This pattern is interesting not 
only because it follows a tight-junctioned, tube-like structure, but also because the only 
varying factor in all of the tested scaffolds was geometry and resulting surface area to 
volume ratio. If, after further testing, it is confirmed that the structures are in fact hollow 
and are epithelial in nature, then the main factor for this type of cell differentiation and 
alignment will be scaffold geometry.  
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7.2 Limitations 
The team faced several limitations while performing this study. The major challenge 
throughout this project was that the printer was outdated and significantly better 
technology is currently available at the same price point. Not only was it not able to achieve 
sufficient resolution, the printer malfunctioned numerous times throughout the course of 
the project. Troubleshooting technical problems was more difficult because the printer was 
user-assembled, not pre-assembled in a factory. The Thing-O-Matic was designed with the 
intention that ABS plastic be used; not PLA or PVA. It was also designed to be used with 3 
mm filament, but in order to create smaller features, the team chose to use 1.75 mm 
filament. The motor deformed the smaller, weaker filament, producing printer blockages 
that occasionally resulted in inconsistent print quality. There were also significant issues in 
how the computer software was integrated with the printer. These problems would 
severely hinder the marketability of the system that was produced, but the team was able 
to work through them to gather results. Newer 3D printer technologies do not possess the 
same limitations and significantly improve the reproducibility and manufacturability of the 
3D fractal molds. 
The ability of PVA to solubilize and degrade in a matter of minutes to hours can be 
considered a limitation in our project. We were unable to show the fractal nature of the 
hydrogel using microscopy. We assume that the fractal nature allowed the cells to 
proliferate better and form the complex structures compared to control scaffolds by virtue 
of better nutrient delivery through the channels created by the fractals. One factor that may 
have contributed to this problem is the swelling property of hydrogels that may narrow the 
channels and hence not be detected by phase contrast microscopy. Additionally, the micron 
level fractal geometry may be destroyed by squeezing pressures exerted on the gel during 
histological sectioning.  
Another limitation faced was the inability to quantitatively evaluate cell growth in our 
final tissue scaffolds. A possible method to quantify cell populations in each scaffold is to 
use a Quant-iT PicoGreen dsDNA Kit from LifeTechnologies (Li et al., 2012). Alternatively, 
scaffolds could be digested to isolate cells and quantified using hemocytometer or 
automated cell counting systems. 
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7.3 Manufacturability 
Our tissue scaffold design and methods have shown promising results, so it is worth 
considering the manufacturability of this product, and what must be changed and 
improved to optimize the manufacturing of these tissue scaffolds. Primarily, 
manufacturability can be significantly improved with a 3D printer using newer technology. 
Additionally, newer technology will enable more complex fractal generation and increase 
fractal reproduction reliability. 
An improved 3D printer can help with every aspect of the PVA mold production. A 
better printer can enable the use of more complex fractals, can make them more 
reproducible, and can help produce them faster and on a larger scale. A printer designed 
for printing PVA can also enable the molds to be printed smaller and with thinner walls, 
optimizing degradation times. Higher processing power may lead to more complex fractal 
geometries with higher surface area to volume ratios. 
7.4 Political, Ethical, and Sociological Ramifications 
This section will discuss various hopes and concerns that this study may affect in 
many different aspects of society. Though the premise of this project focused on the 
economic feasibility of a 3D printer, the team also assessed the environmental impact, 
societal influences, political ramifications, ethical concerns, health and safety issues, and 
sustainability of the fabrication process developed.  
The printer that this project was based on is economically feasible for a wide variety 
of research, clinical, or hospital settings. The Thing-O-Matic is very affordable, priced under 
$2,000 USD, and facilities with little resources may not have a very difficult time attaining 
the equipment needed. For those organizations that may have sufficient resources, it 
should be advised that they use more durable printers with better resolution and more up-
to-date software and hardware. Should this fabrication process of creating 3D scaffolds 
succeed in further research, it is hopeful that 3D printers become more widely available 
and manufactured on a larger scale. The main economic concern affiliated with this study 
stems from the laboratory resources used – the method used to care for and culture the 
scaffolds in vitro could be much more efficient with a lesser use of DMEM and cell culture 
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materials. The amount of training and expertise required will also play a role in the 
economic impact of this process. 
This project presents both positive and negative environmental impacts. These 
concerns also tie into the sustainability of the process that was developed. The material 
that is used as the mold for our scaffold, PVA, is degradable; however the particles may 
negatively affect the environment. It has been shown that, when red pepper plants are 
cultivated in soil containing PVA, it retards their growth (Lee & Kim, 2001). Another 
environmental concern is attributed to the plastic waste created from cell culture 
resources. In the academic year the team worked on this project, cell cultures were 
passaged at least once a week for approximately 20 weeks, which translates to at least 40 
cell culture plates if we kept two plates of cells at all times. These materials are not recycled 
as they are biohazard waste. An environmental advantage of this project is that the printer 
wastes very little material as compared to subtractive fabrication processes. Because the 
molds are manufactured on-site, only what is needed is printed. There is also less 
transportation needed to ship the molds as the plastic filament is bought in a more 
economic manner, so less fossil fuel is used. In rural communities or hard to reach places 
around the globe, this could be a more daunting task that would need many more resources 
in order to transport the materials.  
Socially, the fabrication process that we developed would impact the world and tissue 
engineering in a few different ways. The printer and resources needed would be less 
expensive, and should be more available to research facilities, clinics, hospitals, and 
surgical units. The medicine itself presents a rapid production time because the molds are 
manufactured on-site and could be defect specific. The fabrication process itself is 
relatively simple and the materials used are not extremely difficult to acquire, so this 
technology may become easier to acquire, even for those with limited insurance plans.  
As stated previously, the low cost of this printer would create more opportunities for 
availability of this technology throughout the world. It is also relatively simple to fabricate 
the scaffolds using this method and with commercialization of this process, it would 
become more streamlined. Despite this streamlined process, a surgeon is still required for 
implantation. Regarding the printer itself, there are a wide variety of online forums and 
helpful directions for building, repairing, and adjusting the mechanics and resolution of the 
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printer. Politically, this could greatly improve healthcare throughout the world and tissue 
engineering research.  
The ethical concerns of using this technology include plagiarism, piracy of code, and 
religious concerns. Due to the nature of the programming used to generate and classify the 
fractal structures and use the 3D printer, the resulting code can be easily distributed 
illegitimately. While all copyright information was carefully reviewed in this project, other 
adaptations or similar research could infringe upon copyright information if due care is not 
exercised. The potential for this project to result in tissue regeneration in vivo may disagree 
with the beliefs of certain religions that believe God is the only creator of life.  
In terms of health and safety issues, more long-term testing as well as in vivo testing 
will need to be completed before this process could enter clinical trials or become 
commercialized. The team has not found evidence of long-term in vivo tests using the 
Glycosan Extracel hydrogel. According to Glycosan Biosystems Inc., their Extracel product 
is intended only for research purposes. These tests, as well as any cytotoxicity tests, would 
need to be performed in accordance with FDA regulations. Though the research presented 
proves that we were able to create a 3D hydrogel tissue scaffold, future tests would need to 
prove that it would survive and integrate within the body. 
In regards to sustainability, the amount of waste generated by this process is not 
ideal; however the process itself can be modified and adapted to future works. The amount 
of plastic used without the ability to be recycled has a negative impact on the environment. 
However, with the optimization of the manufacturing process, the development of these 
hydrogel tissue scaffolds could occur in one place. In addition, the process was created with 
change in mind. The experimental protocols for printing molds can be optimized based on 
the desired needs, and capabilities of the printer. With these changes available, the process 
developed is applicable to many situations.   
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Chapter 8. Conclusions and Recommendations 
Our design consists of two primary components, computational modeling and the 
fibroblast cell culture within the hydrogel scaffold. This section reviews the conclusions 
drawn from each design aspect and provides recommendations for continuations of this 
project.  
8.1 Objectives 
The main objective of this project was the optimization of 3D tissue scaffold 
geometry, material, and surface area to volume ratio. This objective was clearly met 
through the proliferation and alignment of cells within the scaffolds and specifically the 
alignment seen in the scaffolds having the highest surface area to volume ratios.  
Computational background and CAD modeling was also an important aspect of this 
project. The team was able to model each scaffold using MatLab, Incendia, Netfabb Cloud, 
and SolidWorks and mathematically calculate the surface area to volume ratio for each 
scaffold group.  
The fabrication technique we used is not optimal for large-scale manufacturing, but is 
adapted for our smaller-scale research purposes. The fractal generation and production 
procedures can be feasibly adapted to faster, larger-scale 3D printers with minimal 
modification. 
The use of an inexpensive 3D printer met our last objective of cost and therefore all of 
our objectives derived from the client’s needs were met by this research. We exceeded the 
project budget initially assigned to us due to the cost of the hydrogel, so a more cost-
effective alternative should be identified for further experimentation.  
8.2 Future Improvements and Recommendations 
While the overall goals of this project were met, improvements can be made to better 
the manufacturability and results of this project. Firstly, a 3D printer that has better 
reproducibility and accuracy should be purchased. With growing interest in 3D printing, 
there are many companies offering low-cost printer options that will yield higher quality 
results than the MakerBot Thing-O-Matic printer can provide. Printing in a sterile 
environment will also reduce the risk of contamination when cells are introduced.  The 
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team chose the patterns we used not only because of their fractal nature but due to their 
ability to be easily printed. With a newer model printer, more fractal options can be 
explored and the surface area to volume ratio can be greatly varied.  
The type of hydrogel used may also be explored. If a natural hydrogel or other 
synthetic hydrogel matrix is proven to work similarly to, or even improve the results found 
in this study then it may be a better option due to economic costs.  
Confirmation of the amount of living cells should be quantified using live/dead 
staining. While we were able to qualitatively show that cells were proliferating and 
aligning, no quantitative data was gathered. This will be the next step in validating the 
results of this study.  
A major aspect of this project that should be further developed is the confirmation of 
the identity of the tube-like structures. Immunocytochemical analysis using a panel of 
specific markers across various tissues would be required to identify the structures. 
Further, the cell seeded scaffolds need to be cultured over a longer period of time to allow 
the structures to grow, differentiate, and mature before final analysis. The formation of 
more pronounced and robust structures in fractal scaffolds compared to the control slab 
scaffold is highly significant because it supports the hypothesis that higher surface area to 
volume ratios enable robust cell growth compared to necrotic cores reported in previous 
studies. This suggests better nutritional supply to cells that are embedded deep in 3D 
scaffolds. It is also imperative to determine if various stiffness of the hydrogel can affect or 
influence cell growth and formation of other structures. If the geometric difference was the 
main factor in the possible alignment and differentiation of these cells, then this would be 
an important result that engineers and scientists could use to benefit their research.   
8.3 Future Printer Selection 
An important future consideration in this project is the purchase of an improved 3D 
printer to achieve better resolution, print speed, and consistency. In this section, currently 
available affordable 3D printers (< $5000) will be compared to our current device – the 
MakerBot Thing-O-Matic. It is important to note that, during our time with the Thing-O-
Matic, we were unable to achieve the claimed resolution and speed, and we were not able 
to have consistent prints in any material other than ABS. While most of the currently 
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available printers do not explicitly support PVA printing, and therefore might not 
demonstrate the same reproducibility and resolution as they do with ABS, they are likely to 
be better than the Thing-O-Matic due to improved extruder tip designs. 
Newer affordable 3D printers have begun to focus on Resin-based 3D printing 
methods. While these new printers provide significantly better resolution and part 
reproducibility, the resin cartridges are significantly more expensive than plastic filaments 
and none of commercially affordably available resins are water-soluble or biocompatible 
like PVA. Therefore, we will focus on identifying an improved fused deposition 3D printer 
to use with PVA, as we are doing now. Priority will be given to positional and printing 
resolution, as well as printing speed to improve the manufacturability of the water-soluble 
PVA molds. Cost will only be considered to stay under the $5000 limit and if very similar 
printers are being compared. Platform size will not be considered important because the 
PVA molds we are printing are relatively small. 
The market has recently been flooded with affordable fused deposition printers. This 
increased competition has led to significant improvements in resolution, speed, 
consistency, and overall print quality. Smaller nozzles, more accurate motors, better 
temperature control, smoother platforms, and tighter tolerances on stepper extruders have 
all improved print quality and speed. A comparison of many of the currently available 3D 
printers is contained in Table 33 below. 
Table 33: Affordable 3D Printer Specifications and Prices. 
Printer Name 
X/Y Min. 
Resolution 
(mm) 
Min. Layer 
Thickness 
(mm) 
Extrusion 
Speed 
(mm/min) 
Cost 
(USD) 
MakerBot Thing-O-
Matic 
0.10 0.30 1000 $1250 
Makerbot Replicator 
2 
0.10 0.10 5000 $2199 
The Ultimaker 0.05 0.04 5000 $1900 
RepRap Prusa 
Mendel 3D 
0.10 0.30 
Based on 
Config. 
$1225 
Stratasys Mojo 0.178 0.178 Not reported $9900 
3D Touch 0.125 0.125 Not Reported $3000 
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 Based on the results from the Table above, the Ultimaker appears to have the best 
layer thickness, resolution, extrusion speed, and price. Additionally, reviews indicate that 
the Ultimaker seems to meet and even exceed its reported resolutions and speeds. Thus, it 
should be used for future PVA molds printed for this project. No printers were found 
between the $3000-$5000 price range, as professional 3D printers such as the Stratasys 
Mojo begin around $10,000 with little improvement over the $2500 affordable, consumer-
grade printers.  
8.4 Impact 
This research is unique in its computational and biologically inspired approach to 
achieving optimal tissue scaffold geometry, maximizing media availability to cells 
throughout a scaffold. Our results indicate that 3D structures with higher surface area to 
volume ratios and fractal dimensions enable greater nutrient perfusion in a tissue scaffold 
and allow for cell alignment and proliferation. By using an inexpensive 3D printer, we 
reduced fabrication cost and enabled the repeatable fabrication of complex fractal 
geometries. 
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Glossary 
 3D Printing: The creation of a three-dimensional shape by stacking two-dimensional 
layers by a variety of different methods.  
 Fused Deposition Printing: 3D printing by the extrusion of layers of melted plastic 
that fuse together before cooling down and hardening into a three-dimensional 
shape. This is the method of 3D printing being used for this project. 
 Biomorphic: Design that attempts to emulate principles found in nature. 
 Biomimetic: Design that copies natural shapes and processes. 
 Thermoplastic: A plastic that becomes deformable above a specific temperature, 
then becomes solid again once below that temperature.  
 Media / DMEM: A liquid containing the nutrients necessary for cell growth in culture. 
DMEM stands for Dulbecco’s Modified Eagle’s Medium and is one of the many 
different kinds of media that are commercially available.   
 Hydrogel: A hydrophilic network of polymers that readily absorbs large amounts of 
water. 
 Fractal: A geometric structure in any number of dimensions that is self-similar at 
different levels of zoom. 
 Self-Similar: A term describing a structure that is similar to itself. Geometric 
similarity describes structures that have the same shape.  
 Tissue Scaffold: A structure designed to promote the growth of three-dimensional 
tissues.  
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Appendix A: Gantt Chart 
The Gantt chart for this project is included in the following pages, ordered left to right 
then top to bottom. 
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Appendix B: Glycosan Biosystems Inc. Extracel Protocol 
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Appendix C: Matlab Code 
Below is the MatLab code that can be used to generate an Iterated Function System 
fractal from a defined base shape.  
 
  
% define the seed shape of the fractal 
vertices = […] 
faces = […] 
 
% choose the level of recursion 
recursionLevel = 3 
 
figure 
genFract(vertices,faces,recursionLevel) 
axis equal off 
 
% fractal generation algorithm 
function genFract(vertices,faces,level) 
if n > 0 
newVert = vertices; 
for k = 1:length(vertices) 
newVert(:,1) = vertices(:,1)+vertices(k,1); 
newVert(:,2) = vertices(:,2)+vertices(k,2); 
newVert(:,3) = vertices(:,3)+vertices(k,3); 
if n == 1 
patch(‘vertices’,newVert,‘faces’,     
 faces,’facecolor’,’r’); 
end 
genFract(newVert, faces, n-1); 
end 
end 
return 
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Appendix D: Fractal Mold Images  
Below are representative images of each printed PVA fractal mold. 
Image Fractal Mold Name 
 
 
 
Cluster Fractal 
(Menger Sponge) 
 
 
 
Tree Fractal  
(Bifurcating Fractal Tree) 
 
 
 
Sierpinski Triangle Fractal 
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Fern Fractal 
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Appendix E: BrdU Protocol 
 
BrdU Protocol 
1. Add 1.0 µL of BrdU stock solution per mL of culture medium to cells being assayed 
and incubate overnight. 
2. Aspirate culture medium and was cells 2X in DPBS+. 
3. Aspirate DPBS+ and add ice cold (-20°C) methanol (1.0 mL/well for a 24-well plate). 
Incubate for 10 minutes at -20°C.  
4. Aspirate methanol and wash with 1.0 mL PBS for 10 minutes.  
5. Aspirate PBS and add 750 µL 1.5 N HCl and incubate at RT for 20 minutes.  
6. Wash 3X with PBS, 5 minutes each.  
7. If cells were cultured with serum, blocking is not necessary. If cultured in serum-
free system, block at RT for at least 15 minutes with 5% FBS in PBS +0.05% Tween-
20.  
8. Dilute anti-BrdU antibody 1:100 in PBS +0.05% Tween 20. 
9. Add 200 µL antibody solution and incubate at RT for 30 minutes.  
10. Aspirate antibody solution and wash 3X with PBS for 5 minutes each.    
11. Add 200 µL fluorescent dye conjugated secondary antibody diluted 1:500 in PBS 
+0.05% Tween-20 and incubate at RT for 30 minutes. 
12. Wash 3X with PBS (without Tween) for 5 minutes each.  
13. Add 0.5 µg/mL Hoechst 33342 to last wash, and incubate at RT for 10 minutes.  
14. Aspirate Hoechst solution, wash with PBS and add 1.0 mL of PBS.  
15. Observe cells under fluorescence microscopy.  
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Appendix F: Leica CM3050 Cryostat Microtome SOP 
Worcester Polytechnic Institute         SOP 3.0 Leica CM3050 Cryostat 
60 Prescott Street                   11/1/2012 
Worcester, MA 01605                                                                          Page 1 of 6 
 
 
Written By Hans B Snyder 
 
Instrument Operating Procedure 
 
I. PURPOSE: To describe procedures to be followed for the inspection, use, 
calibration/standardization, testing, maintenance and cleaning of: 
 
A. Instrument: Leica CM3050 Cryostat Microtome 
B. Manufacturer: Leica Microsystems Nussloch GmbH,  
 Heidelberger Str. 17- 19, D-69226 Nussloch, Germany 
C. Model: CM 3050 
D. Serial (fabrication) No: 2170/02.1999 
E. Location: Gateway Park Room 3237 
 
Note: This SOP is written specifically for use when conducting non-clinical research 
studies in support of faculty and student projects. 
II. DEFINITIONS: 
A. The cryostat is a rotary microtome contained in a mechanically refrigerated 
chamber.  Tissue samples are frozen in poly vinyl alcohol eg, OCT 
Compound, to make it firm enough for sectioning.  The Leica CM 3050 
operates at temperatures of –40 - 0ºC and is able to cut sections 0.5- 60 
μm in thickness.  Disposable microtome blades are used for sectioning. 
Microtome blades have an extremely sharp edge and care must be used 
when handling them.  This cryostat is NOT for use with bio-hazardous or 
infectious materials. 
B. The automated rotary feature of the cryostat prevents injuries associated 
with repetitive motion.  Once the user is comfortable with the use of the 
cryostat, the automated motor function will be very useful.  However, the 
automated feature can introduce risk to the user if users do not adhere to 
the operation protocols. 
III.      REQUIREMENTS: 
All users of the Leica CM3050 are required to undergo proper training in 
frozen sectioning.  All users must read the operators’ manual and familiarize 
themselves to the parts of the cryostat and their functions.  Everyone is 
required to log in usage time for cost recovery.  Equipment and work areas 
must be cleaned thoroughly after use.  Equipment failure must be reported 
immediately to Hans Snyder.  Users are required to bring their own OCT, 
plus slides, forceps, brushes, gloves and Kimwipes.   
*Before using the Leica CM3050, users should familiarize themselves with the location 
of the first aid kit, telephone and emergency exit. 
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Worcester Polytechnic Institute         SOP 3.0 Leica CM3050 Cryostat 
60 Prescott Street                   11/1/2012 
Worcester, MA 01605                                                                          Page 2 of 6 
 
 
Written By Hans B Snyder 
 
 
 
III. INSPECTION: 
 
A. Before use, check to make sure that: 
 
1. 15 minutes before your session, adjust chamber temperature to -20ºC 
(the optimum cutting temperature for most tissues).  Trim specimen to 
desired size.   Apply a small amount of OCT to the specimen disc.  Place 
specimen into OCT and then apply more OCT to surround tissue.  Do 
this quickly as the matrix with start to solidify immediately. 
 
IV.        USE:  
 Note: Only qualified personnel that have been trained in the use of the 
Leica CM3050 Cryostat by Hans B Snyder, Vicki Huntress or other 
designee may use the microtome. 
  
1. Lock hand wheel in the upper position.  Loosen clamping screw.      
Insert specimen disc in opening, tighten clamping screw.   Insert 
disposable microtome blade into the blade holder.  Unlock hand wheel.   
Use motorized coarse feed to bring specimen close to knife.  Select 
desired trimming thickness.  Move anti-roll plate away from knife and 
then rotate hand wheel to trim specimen down to desired sectioning 
plane.  Press trim/section button to start sectioning, select desired 
sectioning thickness, lower anti-roll plate and start sectioning.  Rotate the 
hand wheel evenly and at uniform speed.  Discard the first 2-3 sections 
to ensure that desired thickness is achieved.  To remove the specimen 
disc, lock hand wheel in the upper position, loosen clamping screw and 
remove specimen disc.  Use extreme care near disposable microtome 
blade. 
 
2. For motorized function, center hand wheel grip.  Depress foot pedal 
gently to start the course feed for trimming specimens and to start fine 
feed in sectioning mode.  Emergency stop function is activated by 
depressing the foot pedal forcefully or pressing the emergency stop 
button.  To deactivate the emergency stop function, release the foot 
pedal.  In the case of the emergency stop button, rotate the button in the 
direction of the arrow until it unlocks and slips upward to its original 
position.  To continue work, select one of the sectioning modes (1-2- 3) 
to resume sectioning.  
 
*Always remember lock hand wheel in the upper position when inserting or 
removing specimen disc into microtome or changing disposable blades. 
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V. CONTINGENCY PLAN AND REPORTING: 
 
Minor cuts, which do not require medical aid should be treated at once.   In case of 
a more serious injury (a deeper cut or greater extent of bleeding), Emergency 
extension 5555 should be called to get the injured person to immediate medical 
care.  All injuries must be reported to Worcester Polytechnic Institute using the 
accident reporting form.  The Injury/Incident Report must be forwarded to the 
histology technician within 24 hours.  The SOP for cleanup of human blood should 
be followed. 
 
VI. WASTE MANAGEMENT: 
 
No biological materials are to be left in the cryostat.  All leftover tissue should be 
disposed of properly. 
 
All spent blades are to be disposed of properly and should not be left in the 
cryostat.  Please dispose of sharps in an appropriate sharps container. 
 
VII. MAINTENANCE AND CLEANING: 
 
A. Routine: 
 
1. Before cleaning  
a. Lock the rotary hand wheel. 
b. Remove the microtome blade from the knife holder. 
c. Remove knife holder base and knife holder for cleaning 
2. Disinfection and cleaning 
 
• Prior to disinfection, switch the instrument off and unplug it from mains. 
 
• For disinfection, wear protective gear 
(gloves, mask, lab coat etc.)! 
 
a. Removing/reinstalling the microtome 
 
1. Before removing the  microtome 
• Switch instrument off. 
• Unplug from mains. 
• Place hand wheel grip in lowest position and lock. 
 
 
2. Removing  the  microtome  
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• When removing the microtome, the specimen head must always be 
locked in the lowest position. Otherwise the upper part of the slot 
cover might be bent and consequently damaged! 
      
• Wear gloves when removing the micro- tome while it is still frozen.                                                                                                  
* Risk of frost bite! 
 
• On instruments with specimen cooling do not distort the                    
refrigerating tube! If distorted it might break, causing extremely 
cold refrigerant to escape.                                                                   
* Risk of frost bite! 
 
   3. Disinfection 
   
• For disinfection, only use alcohol-based disinfectants! 
 
• Do not use solvents (xylene, acetone etc.) for cleaning or 
disinfection! 
 
• Do not spray disinfectants into the evaporate-tor! 
* Risk of icing! 
 
• Explosion hazard when working with alcohol Make sure the 
premises are appropriately ventilated! 
 
• When using disinfectants and detergents, comply with all safety 
instructions supplied by the manufacturer of the product! 
 
• Dispose of waste liquids from disinfection/ cleaning as well as of 
sectioning waste ac- cording to applicable regulations on disposal 
of special category waste! 
 
• Disinfected accessories must be thoroughly dry when reinserting 
them into the chamber! 
* Risk of icing! 
 
4. Before re-installing the  microtome 
 
• Make sure the chamber is completely dry before switching the 
instrument back on. 
 
• Humidity in the interior of the micro- tome freezes and causes the 
microtome malfunctions and/or damage to the microtome. 
* Explosion hazard through alcohol vapors! 
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* Risk of icing! 
 
• All accessories/tools removed from the cryo-chamber must be 
thoroughly dry be- fore putting them back into the chamber! 
* Risk of icing! 
 
 
 
 
VIII. MALFUNCTIONS and REPAIR: 
A. In case of a malfunction, notify the histology technician.  In case of 
emergency call Hans at 508-308-7800.  Describe the problem and any 
corrective action taken on the Instrument/Equipment log. 
 
IX. PERSONS RESPONSIBLE FOR EACH OPERATION: 
 
A. Persons responsible for operating the cryostat will be properly trained in its 
use. 
 
B. Training and experience will be reflected in the user’s Curriculum Vitae. 
 
 
X.  REFERENCES: 
 
- Leica CM3050 Instruction Manual 
- Manual of Histologic Staining Methods of the Armed Forces Institute of    
Pathology, 3rd ed. 
 
 
APPROVED BY:   DATE    
Management 
 
 
 
 
APPROVED BY:   DATE    
Professor 
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Instrument/Equipment Inspection, Testing, and Maintenance Log 
 
Instrument/Equipment: Leica CM3050 Cryostat Model #: CM3050         Serial #:   2170/02.1999 
 
 
 
Initials 
 
 
Date 
 
 
Inspection 
 
 
Calibration 
 
 
Testing 
 
 
Maintenance 
 
Follow 
SOP? 
 
 
Comments / Number of Blocks 
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Appendix G: H&E Protocol  
 
 
Gateway Park Core labs 
          Protocol  Procedure 
GPV-000.1 
H&E Frozens 
Approved By:__________________ 
Approval Date:_________________ 
 
Page 1 of 1 
Written By Hans B Snyder  11/27/2012 
1. Hydrate slides in running water-------------- 5 minutes 
2. Stain slides in Harris Hematoxylin -----------10 minutes 
3. Rinse slides in running water -----------------2 minutes 
4. Differentiate in acid alcohol ------------------1 quick dip 
5.   Rinse in water ----------------------------------3 dips 
6.   Dip in ammonia water ------------------------15-30 seconds 
7.   Wash in running tap water ------------------10 minutes 
8.   Place in 95% alcohol--------------------------- 2 minutes 
9.   Stain in eosin ------------------------------------1 minute 
10.   Dehydrate in 95% alcohol --------------------1 minute 
11.   Dehydrate in 95% alcohol --------------------1 minute 
12.   Dehydrate in 100% alcohol ------------------1 minute 
13.   Dehydrate in 100% alcohol------------------ 2 minutes 
14.   Dehydrate in 100% alcohol------------------ 2 minutes 
15.   Clear in xylene I--------------------------------- 2 minutes 
16.   Clear in xylene II--------------------------------5 minutes 
Results: 
Nuclei – Blue 
Cytoplasm – Pink 
Blood -- Red 
Note:  Slides can stay in the last xylene for days without effect. 
No Control. 
 
Revision History 
Revision Approval Date Changes Purpose 
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Appendix H: Sigma Aldrich HyStem-C Protocol 
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Appendix I: Sigma Aldrich HyStem-HP Protocol 
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Appendix J: Final Experiment Protocol  
Procedure 
1. Print 3 of each PVA mold using a nitrogen purge using short bursts of nitrogen after 
initially purging for 5 minutes.  
2. After printing, bring the mold inside a cell culture hood, dip in sterile 70% ethanol, 
shake off excess ethanol and then place in a weigh boat 
3. Turn on the hood UV light and sterilize the molds for 20 minutes 
4. While the molds are being sterilized: 
a. Extract the necessary amounts of Extralink, Gelin-S, and Glycosil 
b. Place the corresponding amount of Gelin-S and Glycosil into microcentrifuge 
tubes labeled for each mold 
c. Spin down NIH3T3 cells and resuspend so there are 2.28 x 106 cells per 
0.5mL 
5. When the molds are done being sterilized and the gel components are ready to be 
plated, mix in the corresponding amount of Extralink for 1 mold into its 
microcentrifuge tube 
6. Wait 8 minutes to allow gelation to start 
7. At 8 minutes, add the calculated amount of cell suspension and top off with media 
bringing the total volume to 0.5mL 
8. Mix via pipetting and inject into the mold 
9. Set the mold aside to allow gelation to complete 
10. Plate the other molds 
11. When gelation is complete, place molds in a labeled 100mm TCP and cover with 
media 
12. Place the TCP in an incubator on a shaker 
13. Monitor PVA degradation and change media when the media becomes opaque with 
PVA 
14. Keeping monitoring and changing the media until the PVA mold is dissolved 
15. When all the PVA is dissolved, transfer the gel to a 30mm TCP using a sterile plastic 
spatula 
16. Cover the gel with media and incubate on the shaker 
17. Image the gels and change out half the media  daily 
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Appendix K: Glycosan Hydrogel Digestion Protocol 
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Appendix L: MatLab Code Usage License 
Below is the code license provided for the script used to compute Fractal Dimension 
and Lacunarity. 
 
Copyright (c) 2010, Omar Al-Kadi 
All rights reserved. 
 
Redistribution and use in source and binary forms, with or 
without  
modification, are permitted provided that the following 
conditions are met: 
 
 * Redistributions of source code must retain the above 
copyright notice, this list of conditions and the following 
disclaimer. 
 * Redistributions in binary form must reproduce the above 
copyright notice, this list of conditions and the following 
disclaimer in the documentation and/or other materials 
provided with the distribution 
       
THIS SOFTWARE IS PROVIDED BY THE COPYRIGHT HOLDERS AND 
CONTRIBUTORS "AS IS" AND ANY EXPRESS OR IMPLIED WARRANTIES, 
INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF 
MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE ARE 
DISCLAIMED. IN NO EVENT SHALL THE COPYRIGHT OWNER OR 
CONTRIBUTORS BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, 
SPECIAL, EXEMPLARY, OR CONSEQUENTIAL DAMAGES (INCLUDING, BUT 
NOT LIMITED TO, PROCUREMENT OF SUBSTITUTE GOODS OR SERVICES; 
LOSS OF USE, DATA, OR PROFITS; OR BUSINESS INTERRUPTION) 
HOWEVER CAUSED AND ON ANY THEORY OF LIABILITY, WHETHER IN 
CONTRACT, STRICT LIABILITY, OR TORT (INCLUDING NEGLIGENCE OR 
OTHERWISE) ARISING IN ANY WAY OUT OF THE USE OF THIS SOFTWARE, 
EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGE. 
